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1 Introduction
1.1 Chiroptera (bats)
The class of mammals comprises more than 5,000 species. They all share the char-
acteristics for classification like a coat which goes along with an endothermic living,
breast feeding, and almost all are live bearing [39]. Most of the mammals are ter-
restrial, some are aquatic and some are even able to fly [39]. Flying mammals are
represented by the order Chiroptera (bats), which form the second largest order
within the mammals (20%) [179, 169]. The highest abundance of bats with the
greatest species diversity can be found in the tropical regions [104]. With the de-
velopment of special skills like active flying and the echolocation for orientation and
hunting, bats were able to settle on all continents except Antarctica [179]. They can
form colonies in highly diverse ecological niches (Figure 1.1) [89].
(a) (b)
Figure 1.1: Examples of typical bat quarters.
(a) The Kalkberg Cave in Bad Segeberg, Germany, is a hibernation side for around 20,000
bats (®Noctalis). (b) In tropical regions, some bat species form quarters in trees like in
Kumasi, Ghana (® Institute of Virology, Bonn).
Chiroptera are subdivided into two suborders Yango- and Yinpterochiroptera.
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Yangochiroptera comprise three bat super families: Emballonuroidea, Noctilionoidea
and Vespertilionoidea. These include the insectivorous species Myotis daubentonii
(M. daubentonii), Pipistrellus spec. (both Vespertilionidae), Tadarida brasiliensis
(T. brasiliensis, Molossidae) and Hipposideros cf. caffer/ ruber (H. cf. caffer/ruber,
Hipposideridae). The suborderYinpterochiroptera includes frugivorous/nectarivorous
bats (flying foxes) with species like Rousettus aegyptiacus (R. aegyptiacus), Pteropus
alecto (P. alecto) and Eidolon helvum (E. helvum) as well as the insectivorous bat
Rhinolophus cf. landeri (R. cf. landeri, Rhinolophidae)[195][89]. The neotropical
fruit bat species Artibeus jamaicensis (A. jamaicensis) belongs also to the suborder
Yinpterochiroptera, family Phyllostomidae. It is distributed in Middle and South
America as well as regions of the Caribbean [179].
Migration of bats is closely related to their habitat. Seasonal migration is en-
countered particularly in the temperate zone covering a flying distance between 50
to 1,800 km [104]. Generally, seasonal migration is based on prospecting for sum-
mer quarters for the breeding of pups, and for winter quarters to hibernate in an
environment with a constant temperature [8]. A typical hibernation cave is located
in Bad Segeberg (10°18´57´´E; 53°56´09´´N), Germany, and is inhabited by 20,000
bats from eight different species every winter (Figure 1.1a) [63]. With a constant
temperature of 9°C, it offers optimal hibernation conditions [63]. In the tropical
zones, migration is influenced by the availability of food [104]. Figure 1.1b shows a
roosting bat colony where the animals sleep during the day in trees and go hunting
at night. With the absence of drastic seasonal climate change, hibernation does not
occur in the tropical regions [104].
The second special skill of bats, which enabled the colonization of highly diverse
niches, is the echolocation. Echolocation mainly occurs within the Yangochiroptera
[173]. Bats produce high frequency sounds that are echoed off objects in the sur-
roundings, giving the bats an accurate impression of the landscape, and objects in
their surroundings [89]. The development of this ability has enabled night hunting
and cave-dwelling. The Yinpterochiroptera lack the ability to echolocate, with the
exception of the genus Rousettus [131].
High life expectancy, low reproduction rates and demanding living requirements
make it challenging to use Chiroptera as a model organism in the laboratory. There-
fore, more suitable models like cell cultures are desirable.
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1.1.1 Description of bats relevant to this work
The straw-coloured fruit bat E. helvum belongs to the family of the flying foxes
(Pteropodidae), accounts for the largest bat population in Africa [136] and is widely
spread. These flying foxes are found in the forest and savannah zones south of the
Sahara desert, on the south western part of the Arabian Peninsula and on the island
of Madagascar [136]. The yellowish colour of their coat led to their name [136]
(Figure 1.2a).
(a) (b)
Figure 1.2: Pictures of two bat species relevant to this work.
(a) The flying fox Eidolon helvum (E. helvum) is wide spread over the African continent
with incidences at the Arabian Peninsula and the Island of Madagascar (® Institute of
Virology, Bonn). (b) The Franquet´s epauletted fruit bat, also called Epomops buettikoferi
(E. buettikoferi), is mainly found in western Africa (® Matschie. 1899. Megachiroptera
Berlin Museum: 45).
The social interaction habits between members of E. helvum present a typical
example of the social life of the bats in general [136]. They live in colonies of several
hundred thousand to one million animals and sleep during the day in trees, caves or
buildings in their roosts, while searching for food at night in smaller groups [136].
Their common diet is based on fruits from the Palmyra palm or the date palm,
mangos and ceibas [136]. During foraging bats can cover a distance of 30 km per
night [136].
Due to their widespread occurrence bats often come into contact with human [8].
They are, for example, often encountered close to food markets or plantations where
bats sometimes destroy the harvest [8]. In some regions bats are also part of the
human food chain and are consumed as protein source [216, 73].
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The second bat species of importance in this work is the Franquet´s epauletted
fruit bat, also called Epomops buettikoferi (Epo. buettikoferi). Like E. helvum, it
belongs to the family of Pteropodidae but its distribution is limited to Ivory Coast,
Ghana, Guinea, Guinea-Bissau, Liberia, Nigeria, Senegal, and Sierra Leone [8]. The
primary diet of E. buettikoferi is fruits, like mangos, bananas, figs and guava fruits
[8]. Franquet´s bats are solitary or live in small groups in lowland forests near bodies
of water [8]. Normally they prefer tropical forests and roost in trees [98] (Figure
1.2b).
The speciesMyonycteris torquata (M. torquata) is distributed in West and Central
Africa and known to roost as singles or in small groups, preferring lowland tropics
and primary and secondary forest [133]. However, the species also appeared to
migrate to grassland regions during rainy seasons and, due to their high capacity to
adapt, also in city gardens [133]. The species R. aegyptiacus is spread throughout
Africa, except in the desert regions of the Sahara, and the Middle East, as far east
as Pakistan and in the southern part of Turkey [14]. They occasionally roost in trees
and primarily in natural or man-made caves in large colonies and forage for food
during the night [14]. Both bat species show antibody prevalence for Ebola viruses
and are most likely the reservoir for this virus [150, 151].
1.1.2 Bats as reservoir for human pathogenic viruses
Bats have been shown to host relevant human pathogens like Rabies, Ebola, Mar-
burg, Henipaviruses (Hendra-, Nipah-) and severe acute respiratory syndrome (SARS)-
like Coronaviruses [24].
The human pathogenic SARS-CoV is one example for a zoonosis originating from
bats [108, 149]. First serological studies on wildlife markets identified masked palm
civets (Paguma larvata), racoon dogs (Nyctereutus procyonoides) and hog badger
(Artonyx collaris) to have antibodies to SARS-CoV-like virus [66]. In the following
SARS-CoV-like viruses were identified in the Chinese horseshoe bats (Rhinolophus)
[108] and phylogenetic analysis proved close relation to the human SARS-CoV. The
close contact between human, civets and bats on the wild life markets enabled
effective transmission between reservoir and alternate hosts as well as the dead end
host [184]. In the following years CoV antibodies could be detected in African and
European bat species [63, 134].
The family Paramyxoviridae comprises a large number of human and veterinary
pathogens including measles-, mumps-, parainfluenza- and rinderpest virus as well
as Sendai-, Hendra- ((HeV) in Australia) and Nipah virus ((NiV) in Asia) (genus
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Henipavirus) [99]. First associations with bats (genus Pteropus) as reservoirs were
found for Henipaviruses, which cause fatal encephalitits in humans [73, 49]. Related
viruses exist in a colony of E. helvum fruit bats in Ghana [41] and most recent
studies identified new virus species belonging to the genus Henipavirus found in six
bat species collected in five different African countries [42].
Certain alphaviruses were found in several bat species like Egyptian rousette (R.
aegyptiacus), Sundevall´s leafnosed bat (H. caffer) or the vampire bat (Desmodus
rotundus) [24]. The bats were most probably infected by arthropods. If they play
a role in the life cycle of alphaviruses needs to be analysed. First connections
between bats and SINV were described by Blackburn et al. in 1982 [19], who were
able to isolate the virus from bat organs. ONNV, CHIKV and SINV are primarily
associated with polyarthritis and rash [99]. The representative of the New World
alphaviruses, VEEV, belongs to the Venezuelan equine encephalitis complex [99].
It was first isolated in brains of horses in the Guajira region of Venezuela in 1936
[212]. The outbreak spread to the central valleys of Colombia and later the virus
was also isolated in South America, Central America, the Caribbean islands and the
southern regions of the United States [212]. The main vector of the virus belongs
to the Culex genus [48]. As the name already implicates the virus belongs to the
encephalitis causing alphaviruses [99]. Interestingly, first detections of VEEV in
neotropical bats were described in 1939 by Kubes et. al [101]. In the following years
similar discoveries were made in Equador, Colombia and Mexico as well as in Texas
(USA) [202]. Seymour et al. could identify antibodies against VEEV in bats from
Mexico and Guatemala in 1973 and postulated a role of bats in transmission during
the enzootic cycle of the virus [168]. The serological survey of neotropical bats for
at least 10 different virus antibodies including WEE, EEE and VEEV by Ubico et
al. confirmed earlier findings of antibodies against VEEV in bats for Guatemala,
underlining the evidence of the role of bats in the enzootic cycle of the virus [202].
1.1.3 Cell cultures of bats
The role of bats as reservoirs implicates the question how these mammals deal with
virus infections. Bats are difficult to breed making live animal studies challenging
(1.1). Cell culture systems are a good alternative and are a favoured model to
answer fundamental questions. Commercially available are only the bat cell lines
Tbl-Lu (ATCC number CCL-88, generated from the lung of Tadarida brasiliensis)
and Mvi/It (ATCC number CRL-6012, originated from inter scapular of Myotis
velifer incautus). Crameri et al. presented P. alecto immortalised bat cells, which
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were characterized and could be used for virus-host interaction studies [32]. They
described that the commercially available cells were not infectable with their viruses
of interest [32]. The generation of specific bat cell lines like primary fetal cells
from the Egyptian fruit bat (R. aegyptiacus) traced back on the idea that isolation
and characterization of viruses may be more efficient in the reservoir [90]. For in-
depth studies and virus-host interaction studies in the reservoir, the establishment
of specific cell lines is essential.
1.2 Alphaviruses
Alphaviruses belong to the family Togaviridae and are mainly arthropod-borne vir-
uses. Based on the geographic location from which they were originally isolated,
these viruses could be classified as either New World alphaviruses or Old World
alphaviruses [189]. Old World Alphaviruses include Chikungunya virus (CHIKV),
O´nyong-nyong virus (ONNV), Ross River virus (RRV), Semliki Forest virus (SFV)
and Sindbis virus (SINV). They cause fever, rash and arthralgia syndrome which is
rarely fatal [99]. The representatives of the New World alphaviruses, such as Eastern
equine encephalitis virus (EEEV), Venezuelan equine encephalitis virus (VEEV) and
Western equine encephalitis virus (WEEV), commonly cause encephalitis in horses,
humans and other mammals [158]. Initial studies on alphaviruses focused on the
prototypic SFV and SINV, because both grew to high titers in cell cultures and were
not pathogenic for humans [158]. Recently attention has been directed towards in-
vestigations on CHIKV due to the 2005 outbreak of CHIKV in La Reunion resulting
in over 300,000 cases of infection and 250 fatalities [180].
1.2.1 Genomic composition and virion structure
The alphavirus genome is a single-stranded, positive-sense, RNA genome and com-
prises approximately 12 kb [176, 188]. Subgenomic mRNAs, which encode the struc-
tural proteins are generated during viral replication [176, 188]. Both genome species
contain a 5´cap and a poly (A) tail [99]. Within the coding sequence there are two
open reading frames (ORFs) [74]. The ORF located at the N-terminus encodes for
the nonstructural polyprotein, whereas the C-terminally located ORF is encoding
the structural polyprotein (Figure 1.3) [74].
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Figure 1.3: Alphavirus genome and variations during replication.
Single-stranded, positive-sensed RNA forms the alphavirus genome. It encodes two open
reading frames. In this scheme the early and late processing of the polyproteins is high-
lighted with the identified proteases. nsP, non-structural protein; P123, non-structural
polyprotein of nsP1, 2 and 3; RdRp, RNA-dependent RNA polymerase; CP, capsid; E2
and E1, glycoprotein; 6K, 6K protein (ViralZone:www.expasy.org/viralzone, Swiss Insti-
tute of Bioinformatics).
Viral and host proteases cleave the two polyproteins [74]. The RNA replication is
performed by the four nonstructural proteins and their intermediates (nsP1 to 4),
and for viral encapsidation and budding the five structural proteins (C, E3, E2, 6K,
E1) are needed (Figure 1.3) [74].
In general alphaviruses are found to be small, icosahedral-shaped and enveloped
viruses with approximately 70 nm in diameter [123, 135]. The lipid membrane
surrounding the alphavirus virion is host-cell acquired and has 80 spikes arranged
in a T= 4 icosahedron [56]. The spike protrusions are formed by trimers, which
in turn are assembled by heterodimers of the glycoproteins E1 and E2 (Figure 1.4)
[209].
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Figure 1.4: Scheme of the alphavirus virion.
The scheme depicts the icosahedral structure with highlighted structural alphavirus pro-
teins and the genomic RNA. Capsid protein and the genomic RNA are coloured in green
and the spikes are coloured in yellow (ViralZone:www.expasy.org/viralzone, Swiss Institute
of Bioinformatics).
Newly synthesized viral genomic and subgenomic RNAs are capped and methyl-
ated by the nsP1 protein [4, 132], which is assumed to anchors replication complexes
to cellular membranes during RNA replication [142]. The nsP2 combines three activ-
ities and is mainly active as protease in processing of the nonstructural polyprotein
(Figure 1.3) [64, 206, 154, 74]. ADP-ribose 1-phosphate phosphatase, as well as RNA
binding activity were identified with the help of crystal structures of the CHIKV
and VEEV nsP3 N-terminus [122]. An RNA-dependent RNA polymerase (RdRp)
function was described for the nsP4 protein [69][170].
Viral genomic RNA is bound by the alphavirus capsid protein (CP), during nuc-
leocapsid formation [138, 214]. The role of the structural protein E3 varies between
the different alphaviruses and is, therefore, undefined [112][61][175]. The glycopro-
tein E2 mediates receptor binding [183, 60, 118]. The 6K protein plays an important
part in the alphavirus particle assembly [86, 57] and has also been described as a
viroporin [163, 162, 129]. E1 protein is defined as a fusion protein for all alphaviruses
[21, 137].
1.2.2 Alphavirus Life-Cycle
Alphaviruses enter the cell via receptor-mediated endocytosis [99]. By fusion with
the endosomic membrane the nucleocapsid is released into the cytoplasm (Figure
1.5).
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Figure 1.5: Replication cycles of alphaviruses.
The virus enters a cells via receptor mediated endocytosis. After release of the nucleocapsid
and the viral genome, translation of the nonstructural proteins starts. Formation of a
replication complex allows replication of minus strand RNA, which serves as template
for subgenomic RNA. Here the structural proteins are translated and processed. Final
processing and maturation of pE2 and E1 takes place in the endoplasmic reticulum (ER)
and the Golgi apparatus. Meanwhile the nucleocapsid core assembly and genomic RNA
packaging takes places in the cytosol. The processed structural proteins are transported to
the plasma membrane and form together with the nucleocapsid budding particles, which
are released as mature virions into the intracellular space [166].
Here the viral genome is set free and translation of the nonstructural (P1234) and
structural polyproteins starts immediately [62][36]. Together, the nsps build an un-
stable initial replication complex, which starts to synthesize negative-strand RNA
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[189, 110, 171, 33]. When cleavage is completed to nsP1, nsP2, nsP3 and nsP4,
synthesis of negative-strand RNA is inhibited and the stable replication complex
starts the synthesis of postitive-strand genomic and subgenomic RNA [110, 171].
The replication mechanism is controlled by a leaky termination codon located be-
hind nsP3 resulting in a read-through efficiency of 10-20 % [116]. The structural
polyprotein is cleaved cotranslationally and starts with the autoproteolytic cleavage
of the CP (Figure 1.3) [127, 7, 61]. CP binds to newly synthesized RNA, leading to
RNA packaging and nucleocapsid assembly (Figure 1.5) [214, 138]. The remaining
polyprotein is inserted into the endoplasmic reticulum and is processed by a host
signal peptidase [127, 121]. The budding process is driven by interactions between
CP and the cytoplasmic domain of the E2 protein, leading to envelope formation
around the nucleocapsid-like particles by E1-E2 heterodimers [139, 130, 207]. The
membrane bilayer of the virions is obtained upon release from the host cell plasma
membrane (Figure 1.5) [56, 3, 106, 209].
The early phase of infection is characterized by high virus titers at the primary in-
fection site and leads to fever which is accompanied by a strong increase of interferon
(IFN) (Figure 1.6) [99].
Figure 1.6: Alphavirus infection and clinical consequences.
The three schematic diagrams describe virus replication, immune response to it and
the clinical symptoms of the human body over time illustrating the connectivity
between the three factors [99].
During late phase of infection the virus replication is concentrated on the target
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tissues (like muscle, brain, joints and skin) inducing symptoms like joint pain, rash,
myositis and encephalitis [99]. The adaptive immune response is in parallel activated
(Figure 1.6) [99].
1.2.3 Alphaviruses transmission cycles
ONNV and CHIKV are closely related and belong to the Semliki Forest antigenic
complex [94]. While ONNV is distributed in the central east part of Africa, CHIKV
outbreaks are found in sub-Saharan Africa, South-east Asia, Indonesia and the Phil-
ippines [99]. Although the two viruses are closely related, they have different mos-
quito hosts [205]. CHIKV is transmitted by several species of the genus Aedes [92],
ONNV is the only alphavirus known so far to be transmitted by Anopheles mos-
quitoes, which is the main vector for Malaria [218, 30]. SINV is a member of the
Western equine encephalitis complex and was isolated in Europe, the Middle East,
Africa, India, Asia, Australia and the Philippines [99]. Its vectors are species of two
different mosquito genera, Culex and Culiseta [99].
Viruses, which are transmitted by arthropod vectors (like ticks or mosquitoes),
are summarized as arthropod-borne viruses (Arboviruses) [99]. Arboviruses have a
natural transmission cycle (Figure 1.7).
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Figure 1.7: Transmission cycles of arboviruses.
Three different transmission cycles have been described for arboviruses. The en-
zootic or sylvatic cycle involves wild animals, mostly small mammals or birds and
a vector mosquito and rare human infections. Crossing to a epizootic or epidemic
cycle includes a host change and can additionally include a vector change. The
rural epizootic cycle includes non-wild animals like horses or pigs, while the urban
epidemic cycle has humans as new host ( http://explow.com/sylvatic).
This is called sylvatic or enzootic cycle, in which the virus cycles between wild
animal populations and the lifelong infected vector and humans are normally dead-
end hosts infected by vectors [99]. Often small mammals like rats, opposums, birds
or monkeys are ´hosts` [47, 88]. In most cases the defined vector is only one mosquito
species, but in some cases several mosquito species serve as vectors in the sylvatic
cycle [48]. When a virus changes host, it enters the epizootic cycle [197]. This can be
caused by the usual vector with a mutated virus or it can be due to a so called bridge
vector mosquito (introduction of the virus in a different mosquito, which has e.g.
less specialized feeding habits) [99]. The epizootic cycle is divided in the domestic
or the urban epidemic cycle [99]. In the first case domestic animals like horses and
pigs are involved, in the latter case, humans are the new host [99]. At this stage
humans are the host for the virus and transmission is limited between vectors and
humans (Figure 1.7) [99]. Viruses in the epizootic cycle are highly infectious and
trigger disease in several thousand people or domestic animals [99].
For VEEV it was shown that species of the genus Culex are part of the enzootic
cycle [48]. It was described that the primary vectors during epizootic cycles are
Psorophara confinnis and Aedes sollicitans (Ae. sollicitans), which suggests that a
change in the transmission cycle has taken place [212]. For CHIKV monkeys and
two mosquito species (Ae. africanus, Ae. furcifer) were identified to be involved in
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the sylvatic cycle, while the mosquito Ae. aegypti could be identified to be involved
in the urban epizootic cycle between human and mosquito in Africa [37, 197]. It is
postulated that CHIKV has no enzootic cycle in Asia and, therefore, remains in the
urban cycle (Figure 1.7)[102]. During epidemics of ONNV human-mosquito-human
transmissions have been described [205, 174]. The enzootic vector and vertebrate
reservoir host remain unidentified [205, 174]. For SINV the main mosquito vectors
of the sylvatic cycle belong to the genus Culex and Culiseta with birds as the major
vertebrate host [99]. Entering the urban epidemic cycle is most probably based on
the introduction of the virus into the bridge vector mosquito of the genus Aedes [22].
1.3 IFN response to virus infections
The innate immune response is composed of physical and chemical barriers as well
as cellular response mechanisms (including the IFN response) to prevent viral and
bacterial infections [87]. The first line of intracellular defence to virus infections are
intrinsic immune-related proteins that recognize either viral proteins or viral nucleic
acids (Figure 1.8) [87].
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Figure 1.8: Innate response to virus infection.
The first innate response to viruses can be distinguished between viral proteins and
viral nucleic acids. Viral proteins are recognized by cytoplasmic restriction factors
like Fv (mouse), TRIM-5α (human), or myxovirus resistance (Mx) proteins and by
TLRs. Viral nucleic acids activate kinases protein kinase R (PKR), the general
control non-derepressible -2 (GCN2) and additional kinases which phosphorylate
the eukaryotic translation initiator factor 2 (eIF2α), resulting in the downregulation
of translation. Activation of 2´-5´oligoadenylate synthetase (OAS) is caused by
viral RNA and triggers RNase L and thereby inducing unspecific RNA degradation.
Apoptosis can be induced by both PKR and 2´-5´-OAS. Additionally, mutations in
viral genomes are caused after viral RNA recognition by the adenosine deaminase
acting on RNA (ADAR1) and the apolipoprotein B mRNA-editing enzyme catalytic
polypeptide-like editing complex (APOBEC3G). Viral nucleic acids activate Toll-like
receptors (TLRs), (RIGI-like) receptors (RLRs) and DNA-dependent activator of
IFN regulatory factors (DAI), which induces a signalling cascade with final activation
of IRFs and transcritpion of IFN-αand IFN-β genes. This triggers the expression of
antiviral proteins and thereby the antiviral status.[146]
Capsid proteins of retroviruses are targeted by Fv (murine) or tripartite motif
protein (TRIM) 5α and nucleoproteins of bunya- and orthomyxoviruses are recog-
nized by myxovirus resistance (Mx) proteins [71, 17]. The apolipoprotein B mRNA-
editing enzyme catalytic polypeptide-like editing complex (APOBEC) 3G entail
mutations causing subsequent virus replication by deamination retroviral genomes
(Figure 1.8)[72, 17]. Additional antiviral mechanisms can be activated by viral pres-
ence [160]. The presence of viral RNA activates the kinases protein kinase R (PKR)
and/or the general control non-derepressible -2 (GCN2), causing phosphorylation of
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the α subunit of the eukaryotic translation initiator factor 2 (eIF2α), that leads to
downregulation of mRNA translation (Figure 1.8) [16, 217]. The 2´-5´oligoadenylate
synthetase (2´-5´OAS) is also activated by viral RNA and stimulates RNAse L,
which induces RNA degradation [147]. Finally, viral replication intermediates are
deaminated by adenosine deaminase acting on RNA (ADAR)-1 (Figure 1.8) [160].
Taken together these effects (decreasing protein translation, RNA degradation and
RNA deamination) have strong effects on the cell viability and can lead to apoptosis
[160]. Notably these antiviral responses are only active when a cell is infected and
are directed by pattern-recognition receptors (PRRs), which lead to the expression
of proinflammatory cytokines and chemokines arranging the innate and adaptive
immunity [87]. They recognize lipopolysacchride (LPS) or viral nucleic acids taken
together as pathogen-associated molecular patterns (PAMPs) and can be divided
in three classes, namely Toll-like receptors (TLRs), retinoic acid-inducible gene I
(RIGI-like) receptors (RLRs) and nucleotide oligomerization domain (NOD)-like
receptors (NLRs) [126, 6]. TLRs and RLRs play a major role in regulating the
expression of type I IFNs and several other cytokines. NLRs mainly lead to the pro-
duction of interleukin-1β (IL-1β) through caspase-1 activation [152, 93]. On cellular
level viral infection can trigger natural killer (NK) cells to stimulate dendritic cell
(DC) activation, resulting in the induction of the adaptive immune response (Figure
1.8) [109].
1.3.1 Induction of IFN and cytokines
The intracellular response upon infections consists of gene-regulatory networks that
allow prompt alternations in gene expression [198]. While TLR3, 7 and 9 recognize
PAMPs in the endosomes, the RLRs are located in the cytosol (Figure 1.9).
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Figure 1.9: Scheme of the IFN response of the cell.
After viral entry (for enveloped viruses via endocytosis or fusion with the plasma
membrane) single or double-stranded RNA molecules are released. They are recog-
nized by Toll-like receptors in the endosomes or MDA5 or RIG-I as well as PKR
in the cytoplasm. The recognition actives a cascade of phosphorylation leading to
IRF3 dimerization and its translocation to the nucleus. Here the complex binds to
the IFN promoter and induces IFN-β mRNA expression. The protein is secreted
and activates in an auto- and paracrine way the JAK/STAT-pathway, which induces
an antiviral state of the cell by expressing IFN stimulated genes (ISG). ISGs can
either interact directly by inducing degradation of viral RNA or by inhibiting the
host transcription and in the end by inducing apoptosis [70].
Representatives of the RLRs are RIG-I and the melanoma differentiation-associated
gene 5 (MDA5) and also the laboratory of genetics and physiology 2 (LGP2) [221].
The signalling activity of RIG-I and MDA5 is mediated by two caspase activation
and recruitment domains (CARDs) located N-terminally [193]. All three molecules
share an internal DExD/H-box RNA helicase domain that has ATPase activity
[222]. It was shown that the ATPase activity, activated by ligand binding, is crucial
for signalling [222, 193]. The C-terminal region of RIG-I and LGP2 consists of a
repressor domain (RD), which keeps the molecules inactive until ligand binding oc-
curs. This triggers conformational changes resulting in CARD domain release and
induces signalling [159]. RIG-I and MDA5 bind via the released CARD domain to
the signalling-adaptor molecule, IPS-1, which is located in the outer mitochondrial
membrane (also known as MAVS, VISA or Cardif) [167, 97]. IPS-1 activates in
the following the TANK-binding-kinase 1 (TBK-1) and IκB kinase  (IKK) [50].
This step was detected in both TLR-dependent and RLR-dependent IFN-inducing
pathways [77]. The phosphorylation of the interferon regulatory factors (IRF) 3
and/or 7 results in homo- or heterodimers. Dimerization allows nuclear transloca-
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tion and leads to induction of type I IFNα/β expression [165]. Additionally IPS-1
triggers the activation of the kinase IKKα-IKKβ-transcription factor that stimu-
lates the nucleus-translocation of the nuclear factor-κB (NF-κB). Type I IFN-β
and inflammatory gene chemokine (C-C-motif) ligand 5 (CCL5), also known as
RANTES (Regulated upon Activation, Normal T-cell Expressed and Secreted), are
both induced by NF-κB [128]. Although RIG-I and MDA5 show a high similarity
in structure and induce type I IFN expression, they recognize different dsRNA mo-
lecules. RIG-I recognizes positive and negative stranded RNA viruses (like Hepatitis
C virus, vesicular stomatatis virus (VSV) and influenza A virus) and plays a role in
recognition of DNA viruses [1], while MDA5 is responsible for the recognition of pi-
corna viruses as well as dsRNA and Polyinosin:Polycytidyl acid (poly IC) [194, 96].
Both helicases response to reoviruses, West Nile virus and Dengue virus [96].
1.3.2 IFN secretion and signalling
Three different IFN types have been identified. The type I IFNs have multiple
subtypes with 1 IFN-β and at least 14 known IFN-α substypes. In several species
additional subtypes are known [143]. They can be induced in all nucleated cells upon
viral infection, in contrast to type II IFN (IFN-γ), which can only be secreted by T
lymphocytes and NK cells in response to T cell receptor (TCR) or NK cell receptor
signals [186]. The type III IFNs (IFN-λI, IFN-λ2 and IFN-λ3) are expressed by
separate intron-containing genes [100]. The type I, II and III IFNs have separate
signal receptors, but the downstream signalling molecules are similar. They regulate
many identical genes [186], therefore, only the signalling cascade of type I IFN -β is
described subsequently.
The secreted IFN-β binds to the IFN-α/β receptor. The receptor consists of
two subunits IFNAR-1 and IFNAR-2. The signalling is mediated by the Janus
family of tyrosine kinase (JAK) enzymes together with the signal transducer and
activator of transcription (STAT) family (JAK-STAT) pathway [35]. The STAT
family has at least seven members with stat-1 and stat-2 relevant for the IFN-
dependent response, and the JAK family has in total four, with jak-1, jak-2 and
tyk-2 kinases [34, 111]. JAK-1 and TYK-2 kinases mediate the signalling of IFN -β,
with TYK-2 interacting with IFNAR-1 and JAK-1 with IFNAR-2 subunit. After
IFN -β binding to the receptor, the bound kinases are activated and phosphorylate
the cytoplasmic STAT transcription factors. Phosphorylated STAT1 and STAT2
assemble with IFN-regulatory factor 9 (IRF9) to the IFN-stimulated gene factor 3
(ISGF3) [114, 12]. The heterotrimer translocates into the nucleus and binds to the
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IFN-stimulated response element (ISRE), which is a region of the promoter region of
a great number (> 300) of IFN stimulated genes (ISGs) [81, 20, 54]. The described
intrinsic proteins (section 1.3) belong to this large group of ISGs and IFN triggers
their expression upon viral infection. One of the first described ISGs is ISG56 gene
(the protein is called p56). It belongs to a family of proteins that mediate protein-
protein interactions [113, 107]. p56 inhibits the initiation of translation and protein
synthesis by binding to eIF3 [196]. The Mx protein is a member of the dynamin
superfamily of large GTPase [72] and is strictly dependent on IFN signalling. It
blocks early stages of transcription of specific human and animal viruses by binding
to nucleocapsid proteins [71].
1.3.3 Bioassays to measure secreted IFN
Since the discovery of IFN in 1957 by Isaacs and Lindemann [85], it has been a chal-
lenge to find an appropriate way to determine biologically active IFN concentrations
secreted by virus infected cells. The first established assays were based on reduction
of virus replication due to IFN-mediated protection of the cells [187, 157]. In 1969
Stewart et al. revealed in the discussion about the relative sensitivity of viruses to
type I IFN that the origin of the IFN is critical [187]. The comparison between
mouse, hamster, human, bat and rabbit IFN indicated that the origin of the type I
IFN was critical to its ability to suppress virus growth [187]. The compared type I
IFN was gained differently for each cell line, the following IFN assays were based on
plaque reduction assays [187]. Their work showed the relevance of the IFN source
and might have been one of the first ideas of viral-host interactions.
The most favoured assays to determine bioactive IFN are still based on antiviral
activity. The classical VSV-bioassay is based on the reduction of the cytopathic
effect (CPE), which describes in this case the degree of cell destruction. VSV is
highly sensitive to the antiviral effect of IFN [155] and replicates in cell cultures
derived from many animal species [46]. These characteristics made the virus a tool
for IFN detection. First approaches to determine IFN titers by reduction of CPE
caused by VSV were performed by Rubenstein et al. in 1981 [157]. Although VSV
was reported to have been spread by direct contact among infected animals [185]
and caused devastating epidemics in a range of domestic animals [153], the risk of
biological transmission between infected humans and domestic animals was found
to be very low [2]. Nevertheless, this virus provided an essential tool to the IFN-
bioassay sector. In this study, bioactive IFN, a recombinant pan-species IFN-α
(IFN-α B/D bglII) (synthesized by PBL Biomedical Laboratories) was introduced
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as standard to achieve comparable measurements of secreted [105].
In the presented thesis the focus therefore was put on a virus system that is widely
applicable and can be used in any biosafety level (BSL) 2 laboratory.
1.3.4 IFN response in bats
Since bats host human pathogenic viruses and show the ability to control them, it
was hypothesized that bats might have evolved particularly effective mechanisms
of immune control [191, 213, 220]. Little is known about the immune system of
bats. Development of immunoglobulins after infection and lymphoid development
similar to that in other mammals were detected in bats [124, 26, ?] but in partic-
ular information on the innate immune response of bats is rare. In R. leschenaulti
and P. alecto toll-like receptor genes have been identified [83, ?]. Stimulation with
the dsRNA analogue poly IC, and infection with the bat-associated paramyxovirus
(Tioman) induced high amounts of IFN in cells from Pteropus species [223]. In-
terestingly, infection with the highly pathogenic paramyxovirus Hendra virus did
not induce IFN expression and IFN signalling, suggesting the presence of specific
viral IFN antagonists [208]. Earlier it was described that different mammalian cell
cultures including the bat cell lines Tb1-Lu have a conserved functionality of IFN
signalling [68, 67]. Still, knowledge of the mechanisms by which type I IFNs are
induced and IFN signals are processed in bat cells is limited and further studies are
needed.
1.3.5 Alphavirus antagonism to cellular defence mechanisms
The nsP2 protein of Old World viruses like ONNV, CHIKV and the capsid protein
of VEEV were shown to induce a general transcriptional shutoff [59]. The nsP2 is
translocated into the nucleus, where it impairs the function of the DNA-dependent
RNA-dependent polymerase I and II [58]. Additionally it was shown that nsP2
blocks cellular mRNA translation [51, 53]. The translational shutoff can be PKR-
independent or PKR-dependent [215, 51, 52].The capsid protein of the New World
alphaviruses forms a complex with the importin-α/β and nuclear export receptor
CRM1, that inhibits protein trafficking through the nuclear pore and thereby initi-
ates transcriptional shutoff [10, 11, 9]. Nevertheless, alphaviruses provoke a strong
IPS-1 mediated IFN response in vivo [215], which is most likely due to the incom-
plete inhibition of the cellular antiviral response [59]. The inhibition of STAT1 phos-
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phorylation was recently described for representatives of the Old and New World
alphaviruses but the precise mechanism is not yet analysed, showing that the know-
ledge of alphavirus antagonism is not understood completely and further studies are
needed [178, 177].
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Aim of the thesis
The number of viruses related to severe human diseases found in bats is continuously
growing. Although bats are mammals, it is still not understood how they can cope
with these viruses. The research on IFN response of bats is still at the outset because
adequate tools, which are already at hand for commonly used laboratory animals,
are required to be designed first.
The aim of the present study was to compare the IFN response in bat cell lines to
reference murine (MEF) and human (MA104) cell lines on IFN-induction, -secretion
and -signalling after virus infection. The purpose of this comparison was the evalu-
ation of bat IFN response to virus infection, .
First immortalized bat cell lines were to be established. These cell lines should
be IFN competent which should be tested by challenging the cells with commonly
used IFN inducers. In addition, virus replication efficiency was to be analysed on
genome equivalence concentration and viral particle formation to guarantee equal
infection behaviours in the different cell lines.
A serological survey on prevalence of alphaviruses in bats should be performed
with serum samples collected on three different continents, underlining the distribu-
tion of alphavirus prevalence in bats around the world.
All cell lines were to be challenged with ONNV, because it is as alphavirus a
strong IFN-inducer. To investigate IFN-secretion, the classical VSV-bioassay was to
be adapted to and to be optimized for bat cell lines, enabling unique species-specific
bioactive IFN determination and allowing comparison between different species.
SINV and CHIKV infections were additionally to be performed, to differentiate if
the results with ONNV were virus-specific or were general antagonizing mechanisms
of alphaviruses in bats. SINV was chosen because it belongs to the Old World
alphaviruses and is widespread around the world, while CHIKV was chosen because
of the close relation to ONNV.
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2.1 Materials
2.1.1 Technical equipments
Table 2.1: Technical equipment with design type and source
Equipment Type designation Source
Autoclave Varioklav® Typ 500 H+P Labortechnik,
Oberschleisheim
Balance TP-214 Denver Instrument
Bohemia, New York,
USA
EW2200 - 2NM Kern, Balingen-
Frommern
PM1200 precision
scale
Mettler- Toledo,
Giessen
Bioluminescence,
Luciferase-System
Synergy2,
Multi-detection
Reader
BioTek, Vermont,
USA
Biosafety cabinet HERAsafe®KS12
HERAsafe® KS18
Thermo Scientific
Brunswick
Biotainer 1.8 L E3 cortex, Thieux,
France
Blue screen table VB-26 UVP, Upland,
Californien, USA
Centrifuges 5410 R Eppendorf, Hamburg
5415 Eppendorf, Hamburg
5416 Eppendorf, Hamburg
5418 Eppendorf, Hamburg
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5429 Eppendorf, Hamburg
5430 Eppendorf, Hamburg
5810 Eppendorf, Hamburg
Galaxy MiniStar VWR, Darmstadt
Chemiluminescence
Detection, Western
Blot
FusionFx7 PeqLab/Vilber
Lourmat, Erlangen
Freezer LB 750 (Liquid
nitrogen)
Taylor-Wharton,
Alabama, USA
- 20°C AEG, Frankfurt a.
Main, Kirsch,
Offenburg
- 80°C Kaltis international,
Taiwan
Gel electrophoresis
documentation
E-Box 3028, WL/26 Vilber Lourmat,
Marne-la-Vallee,
France
Gel electrophoresis
chambers nucleic
acids
PefectBlue Gelsystem
Mini S- 50 mL
PeqLab, Erlangen
PefectBlue Gelsystem
Mini L- 100 mL
PeqLab, Erlangen
PerfectBlue
Gelsystem Maxi S-
200 mL
PeqLab, Erlangen
Gel electrophoresis
chambers for proteins
Mini Protean Tetra
System
BioRad, Hercules,
Californien, USA
Glass bottles Duran® Flasks;
different Volumina
Schott, Mainz
Incubator Heraeus® B6126 Thermo Scientific,
Brunswick
Incubator CO2 HERAcell® 240 Thermo Scientific,
Brunswick
Microscopes Inverse TELAVAL 31 Zeiss, Jena
Fluorescence Axio
Imager M1
Zeiss, Jena
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Power supply Standard Power Pack
P25
Biometra, Goettingen
EV202 Consort Turnhout,
Belgium
Pipettes (0.1-2.5µL/
0.5-10µL/ 10-100µL/
100-1000µL)
Research® Plus Eppendorf, Hamburg
Research® Plus Multi
channel pipette
Eppendorf, Hamburg
Pipette assistance Accujet® pro Brand, Wertheim
PCR-Cycler Master cycler ep.
gradients S
Eppendorf, Hamburg
Master cycler Pro
vapo.protect
Eppendorf, Hamburg
pH-meter 766 Calimatic Knick, Berlin
Real-time
PCR-Cycler
LightCycler® 480 II Roche Diagnostics
Basel, Switzerland
Refrigerator 4°C AEG, Frankfurt a.
Main, Kirsch,
Offenburg
Magnetic stirrer MR2000 Heidolph, Schwabach
Shaker MiniRocker MR-1 PeqLab, Erlangen
Spectrophotometer NanoDrop 2000c PeqLab, Erlangen
Thermo mixer comfort 5355 Eppendorf, Hamburg
Thermo mixer PHMT SC-18 Grant-bio,
Cambridgeshire,
Great Britain
Water purification
system
Milli-Q® Biocel Millipore, Schwalbach
Vortex VV3 VWR, Darmstadt
Western blot FastBlot B44 Biometra, Goettingen
Water bath 51221029 Precision Westlock,
Alberta, Canada
Water bath 1092 GFL, Burgwedel
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2.1.2 Disposable materials
Table 2.2: Description of the disposable material and source
Material Description Source
Cell culture flasks 25 cm2 (T25), 75 cm2
(T75), 162 cm2
(T150)
Corning, VWR,
Darmstadt
Cell culture plates 96-, 24-, 12-, 6-well TPP® Trasadingen,
Switzerland
Cell culture scraper 24 cm TPP® Trasadingen,
Switzerland
Centrifugation tubes
(conical)
Falcon-Typ, 15 mL Greiner bio-one,
Frickenhausen
Falcon-Typ, 50 mL Sarstedt, Nuembrecht
Counting chamber C-Chip Neubauer
Improved, disposable
Digital Bio,
TPP®Trasdingen,
Switzerland
Filter paper for
western blots
Gel Blot Paper Whatman, Dassel
Cryotubes Cryo tubes 1.8 mL Sarstedt, Nuembrecht
Mikrotiterplates for
Luciferase-System
LUMITRAC 600
Micro-Plates, 96-well
VWR, Darmstadt
Glass slide 76 x 26 Menzel Glaeser,
Brunswick
Parafilm Brand, Wertheim
PCR reaction plates,
96 well
LightCycler® 480
Multiwell Plate 96
Roche Diagnostics,
Basel, Switzerland
Pipette tips (0.1 mL,
0.5 mL, 1.0 mL, 2.5
mL, 5.0 mL)
Combitips plus Eppendorf, Hamburg
Pipette tips (0.1-10
µL, 2-100 µL, 20-300
µL, 50-1000 µL)
epT.I.P.S.
LoRetention
Dualfilter
Eppendorf, Hamburg
Reaction tubes 0.2 mL Brand, Wertheim
0.5 mL Sarstedt, Nuembrecht
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0.5 mL, Safe-Lock Eppendorf, Hamburg
1.5 mL Sarstedt, Nuembrecht
1.5 mL, Safe-Lock Eppendorf, Hamburg
Serological Pipettes 1 mL, 2 mL, 5 mL,10
mL, 25 mL
Sarstedt, Nuembrecht
Western blot
membrane
Westran Clear Signal
PVDF, 0.45 µm
Whatman, Dassel
2.1.3 Chemicals
Table 2.3: Source of chemicals
Chemical Source
2-Mercaptoethanol (β-ME) Roth, Karlsruhe
β -Propiolacton (β-PL) Ferak® Berlin, Berlin
2-Propanol, Isopropanol, 99.5% Roth, Karlsruhe
6 x Loading Dye (Loading
buffer)
Fermentas, St. Leon-Rot
Acetic acid Roth, Karlsruhe
Agarose, Broad Range Roth, Karlsruhe
Agarose, GTQ Roth, Karlsruhe
Ampuwa®, Sterile pyrogenic free
Water
Fresenius Kabi, Bad Homburg
Ammonium persulfate (APS) Roth, Karlsruhe
Bovine serum albumin (BSA) Roth, Karlsruhe
Bromphenol blue Roth, Karlsruhe
Calcium chloride Roth, Karlsruhe
di-Sodium hydrogen phosphate
dihydrate
Merck, Darmstadt
di-Sodium hydrogen phosphate
Heptahydrate, 98%
Roth, Karlsruhe
Dithiothreitol (DTT) Life Technologies, Darmstadt
dNTPs, 100 mM Set Invitrogen, Karlsruhe
Ethanol, 99.5% Roth, Karlsruhe
Ethidium bromide solution, 10
mg/mL
Sigma-Aldrich® Munich
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Formaldehyde (Roti®-Histofix
4% Formaldehyde)
Roth, Karlsruhe
Glycerine, 99.5% Roth, Karlsruhe
Glycine, 99% Roth, Karlsruhe
Hexaquart plus Braun, Melsungen
Histofix Roth, Karlsruhe
Hydrochloric acid, fuming, 37%
concentrated
Merck, Darmstadt
Igepal CA-630 Sigma-Aldrich® Munich
IMMUMOUNT
(Dakocytomation)
Dako, Hamburg
Incidin® Extra N Ecolab, Dusseldorf
Potassium chloride Merck, Darmstadt
LB-Agar (Lennox) Roth, Karlsruhe
LB-Medium (Lennox) Roth, Karlsruhe
Methanol Merck, Darmstadt
Milk powder Roth, Karlsruhe
Mycoplasma-Off® Minerva Biolabs, Berlin
poly IC Sigma-Aldrich® Munich
Poly-L-Lysin, 0.01% solution Sigma-Aldrich® Munich
Protease Inhibitor Cocktail Set
III ,
EDTA-free
Merck, Darmstadt
Re-Blot Plus-Strong® , 10 x Millipore, Billerica,
Massachusetts, USA
Rotiphorese® Gel 30
(Acrylamid)
Roth, Karlsruhe
Sample buffer IIFT
(Albuminazid)
Euroimmun, Luebeck
Sodium chloride, 94% Roth, Karlsruhe
Sodium dodecyl sulfate (SDS),
Ultra Pure, 99%
Roth, Karlsruhe
S.O.C. Medium Invitrogen, Karlsruhe
SuperSignal® West Femto
Maximum Sensitivity Substrate
Thermo Scientific, Brunswick
SYBR Green, Gel stain (1:1000) Lonza, Cologne
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Tetramethylethylenediamine
(TEMED), 99%
Roth, Karlsruhe
Tris, Ultra Quality Pufferan,
99.9%
Roth, Karlsruhe
Triton X 100 Roth, Karlsruhe
Tween® 20 Roth, Karlsruhe
2.1.4 Buffers and solutions
10% APS - 10 mL
1 g APS
add 10 mL H2O
1 mL Aliquots
Stored at -20°C
Blocking solution for Western blot
5% Milk powder
1 x PBS
0.1% Tween® 20
1 M DTT - 20 mL
1 M DTT
0.01 M Sodium acetate, pH 5.2
sterile filtered
1 mL Aliquots
Stored at -20°C
10 x Phosphate buffered saline (PBS) - 1 L (solution in use 1 x)
1.37 M NaCl
0.03 M KCl
0.1 M Na2HPO4
0.02 M KH2PO4
Radio immunoprecipitation assay (RIPA) lysis buffer
0.15 M NaCl
1% Igepal CA-630
0.5% Sodium Deoxycholate
0.1% SDS
0.05 M Tris (pH 8.0)
add right before use:
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Proteinase Inhibitor (PI) III (1:100)
Benzonase® Nuclease (1:1000)
0.005 M DTT
10% SDS - 1 L
100 g SDS
900 mL H2O
heated to 68°C to dissolve SDS crystals
adjusted pH to 7.2 with HCl
Stored at RT
10 x SDS polyacrylamide gel electrophoresis (PAGE) running buffer
(solution in use 1 x)
0.5 M Tris
1% SDS
3.84 M Glycine
Stored at RT
4 xβ-ME sample buffer (solution in use 1 x)
0.5 M Tris (pH 6.8)
40% Glycerine
8% β-ME
4 g/L Bromphenolic blue
80 g/L SDS
Stored at -20°C
0.01 M DTT added before use
50 x TAE buffer - 1 L (solution in use 1 x)
2 M Tris
1 M acetic acid
0.05 M Na2 EDTA (pH 8.0)
Stored at RT
10 x Transfer buffer - 1 l (solution in use 1 x)
0.25 M Tris
1.5 M glycine in H2O
Stored at RT
10% MeOH added before use
1.875 M Tris HCl buffer (pH 8.8)
Adjusted to pH 8.8 with 37% HCl (concentrated)
Stored at RT
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0.6 M Tris HCl buffer (pH 6.8)
Adjusted to pH 6.8 with 37% HCl (concentrated)
Stored at RT
Dilution solution for antibodies during western blot
1% milk powder
1 x PBS
0.1% Tween® 20
Washing buffer for western blot
1 x PBS
0.1% Tween® 20
2.1.5 Cell culture media
Table 2.4: Media and reagents used in cell culture experiments with source
Media and reagents Source
Amphotericin B PAA, Pasching, Austria
DMEM1 High Glucose (4.5 g/L),
with L-Glutamine
PAA, Pasching, Austria
Dulbecco's PBS (1 x), without
calcium and magnesium
PAA, Pasching, Austria
L-Glutamine (200 mM, 100 x) PAA, Pasching, Austria
MEM with Earle´s salts, with
L-Glutamine
PAA, Pasching, Austria
Imipenem Zienam, MSD, Haar
Nanofectin® PAA, Pasching, Austria
Non essential amino acids
(NEAA) (100 x)
PAA, Pasching, Austria
Sodium Pyruvate solution (100
mM, 100 x)
PAA, Pasching, Austria
Penicillin/ Streptomycin
GIBCO
Invitrogen, Karlsruhe
Trypsin-EDTA (1 x) PAA, Pasching, Austria
Fetal calf serum (FCS), standard
quality
PAA, Pasching, Austria
OptiPROSFM, Serum free
medium GIBCO®
Invitrogen, Karlsruhe
Legend: Dulbecco's Modified Eagles Medium (DMEM)1.
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2.1.6 Cell lines
Table 2.6: Cell lines and description
Designation Tissue Source Organism
A549 Lung adeno-
carcinoma
IVB Homo sapiens
EidNi/41.3 Kidney IVB Eidolon helvum
EidNi41.2 Kidney IVB Eidolon helvum
EidNi/41 Kidney IVB Eidolon helvum
EpoNi/22.1 Kidney IVB Epomops torquata
293 lp Kidney F.W. Homo sapiens
HeLa cervix
carcinoma
IVB Homo sapiens
Hep2 Larynx
carcinoma
IVB Homo sapiens
MA104 Kidney F.W. Chlorocebus sabaeus
MEF Rigi-/- Embryonic IVB Mus musculus
RoNi/7 Kidney IVB Rousettus aegyptiacus
Vero E6 Kidney BNI Chlorocebus sabaeus
Legend: EidNi= E. helvum, Ni= Niere (kidney), EpoNi= E. torquata, Ni= kidney;
IVB, Institute of Virology, Bonn; BNI, Bernhard-Nocht-Institute, Hamburg; F.W.,
Prof. Friedemann Weber, University of Marburg, Department of Virology.
2.1.7 Viruses
Table 2.7: Viruses used in this work
Virus Abbr. Genus,
Family
Source
Recombinant Rift
Valley fever virus
Renilla luciferase del
NSs
RVFV
13
Phlebovirus,
Bunyavi-
ridae
F.W.
O´nyong-nyong Virus ONNV Alphavirus,
Togaviridae
IVB
Chikungunya Virus CHIKV Alphavirus,
Togaviridae
IVB
Sindbis Virus SINV Alphavirus,
Togaviridae
IVB
Vesicular Stomatitis
Virus
VSV Vesiculovirus,
Rhabdovi-
ridae
IVB
Legend: F.W., Prof. Friedemann Weber, University of Marburg, Department of
Virology, IVB, Institute of Virology, Bonn.
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2.1.8 Bacterial strains
For cloning and expression of plasmids used in this work TOP 10® Chemical com-
petent E.coli bacteria from Life Technology (Karlsruhe, Germany) were used.
2.1.9 Kits
Table 2.9: Kits used for extraction ans analysis
Name of used Kit Source
Renilla-Luciferase Assay Systems Promega, Mannheim
NucleoSpin ®RNA Virus MACHEREY-NAGEL, Dueren
NucleoSpin ®8 RNA Virus MACHEREY-NAGEL, Dueren
NucleoSpin ®RNA II MACHEREY-NAGEL, Dueren
NucleoSpin ®8 RNA MACHEREY-NAGEL, Dueren
QIAEX® II Gel Extraction Kit Qiagen, Hilden
QIAprep® Spin Mini Kit Qiagen, Hilden
QIAshredder Qiagen, Hilden
RNeasy® Mini Kit Qiagen, Hilden
2.1.10 Oligonucleotides
Table 2.5: Forward and reverse PCR primer and probes
Assay Name Sequence GenBank ID
Reference
Actin-β (ACTB)
Bat qRT-
bACTB_for
GGCTCCCAGCACAATGAAGA JN613815
qRT-
bACTB_prb
6-FAM-
CAAGATCATTGCGCCC
CCTGAGC-BHQ-1
JN613816
qRT-
bACTB_rev
GGAGCCGCCGATCCA JN613817;
JN613818
Mouse mACTb_for AAATCGTGCGTGACATCAA
AGA
NM_008331.3
mACTb_prb 6-FAM-ATGGAAAGATCAAC
CTCACCTACAGGGCG-BHQ-1
mACTb_rev GGATGGCAAAGGCAGTGT
AACT
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Human qRT_hpmACTB_
fwd
GAGGCATCCTCACCCTGAAG NM_001101.3
qRT_hpmACTB_
prb
6-FAM-CCCCATCGAGCACGG
CATCG-BHQ-1
NM_001009945.1
qRT_hpmACTB_
rev
TCCATGTCGTCCCAGTTGGT NM_001033084.1
IFN-β (IFNB1)
Bat bIFN-B1-F CAGCTATTTCCATGAGCTAC
AACTTG
JN613819
bIFN-B1-Prb 6-FAM-TCGATTCCAACAAAG
AAGCAGCAATTTAGC-BHQ-1
JN613820;
JN613821
bIFN-B1-R TTAACTGCCACAGGAGCTTC
AG
JN613822
Mouse mIfnb1_for AGAAAGGAGGAACATTCGG
AAAT
NM_010510.1
mIfnb1_prb 6-FAM-ATGGAAAGATCAAC
CTCACCTACAGGGCG-BHQ-1
mIfnb1_rev GGATGGCAAAGGCAGTGTA
ACT
Human IFN F GAACTTTGACATCCCTGAGG
AGATT
[80]
IFN P 6-FAM-CAGCAGTTCCAGAAG
GAGGACGCC-BHQ-1
IFN R GGAGCATCTCATAGATGGTC
AATG
ISG56/ IFN-induced protein with tetra-tricopeptide repeats 1 (IFIT1)
Bat qRT-
bISG56_for
TTGAAGAAGCTCTGGCCA
ACA
JN613823
qRT-
bISG56_prb
6-FAM-
ACAGACCTACGTCTTT
CGATATGCAGCCA-BHQ-1
JN613824
qRT-
bISG56_rev
GCGCCTTTTCTTCGGTAA
AA
JN613825;
JN613826
Mouse mIsg56_for TGCCTGGCTGCATTACCA NM_008331.3
mIsg56_prb 6-FAM-
TTGGCAGAAGCCCAG
ATCTACCTGGAC-BHQ-1
33
2 Materials and Methods
mIsg56_rev TGAAAATTCCTTGCACACCT
TCT
Human ISG56 F CCTGGAGTACTATGAGCGGGC[80]
ISG56 P 6-FAM-ACAGAGTTCTCAAAG
TCAGCAGCCAGTCTCAGT
-BHQ-1
ISG56 R TGGGTGCCTAAGGACCTTGTC
MX1/ MxA/ IFN-inducible protein p78
Bat qRT-bMxA_for CCGATC TGACCC TCATCGA JN613827
qRT-bMxA_prb 6-FAM- TGGGCAACCAGCCC
CAGG AC-BHQ-1
JN613828
qRT-bMxA_rev ATGGTCTGCTGCCTCTGGAT JN613829;
JN613830
Mouse mMxA1_for TGAATAATCTGTGCAGGCAC
TATG A
NM_010846.1
mMxA1_prb 6-FAM-
TGCGGCCCTGTTTGAC
CTCATCG-BHQ-1
mMxA1_rev CTGAACTCTGGTCCCCAATGA
Human MxA F TTCAGCACCTGATGGCCTATC [80]
MxA P 6-FAM-
CAGGAGGCCAGCAAG
CGCC
ATC-BHQ-1
MxA R TGGATGATCAAAGGGATG
TGG
TATA box binding protein (TBP)
Bat qRT-bTBP_for TTGCTGCTGTGATCATGAGA
ATT
JN613831
qRT_bTBP_prb 6-FAM- CCCGGACCACGGC
CCTGA-BHQ-1
JN613832
qRT_bTBP_rev CCCGGACCACGGCCCTGA JN613833
Mouse mTbp_for TGTACCGCAGCTTCAAAA
TATTGT
NM_013684.3
mTbp_prb 6-FAM-TCCCAAGCGATTTG
CTGCAGTCATC-BHQ-1
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mTbp_rev AGTTGTCCGTGGCTCTCT
TATTCT
Human qRT_hTBP_fwd GCTGCGGTAATCATGAGG
ATAAG
NM_003194.4
qRT_hTBP_prb 6-FAM-AGCCACGAACCAC
GGCACTGATTTT-BHQ-1
qRT_hTBP_rev TGCACACCATTTTCCCAG
AA
ONNV, Gulu strain
ONNV-S TGATCCAGACTCAACCATTCT M20303.1
ONNV-P 6-FAM-ACCAGCTAGGAGG
ATGATGTCTGA-BBQ-1
ONNV-AS GGCAGACGCAGTGGTATT
TTCT
CHIKV
CHIK-S TGATCCCGACTCAACCATCCT [140]
CHIK-P 6-FAM-
GCCAGCAAGGAGGATG
ATGTCGGA-BBQ-1
CHIK-AS GGCAAACGCAGTGGTACT
TCCT
SINV
SINV-S AAGAACGAGGACGGAGATG
TCA
in house assay
[161]
SINV-P 6-FAM-
CGGGCACGCACGCAC
TGGCCATG-BBQ-1
SINV-AS TTTCACgTgCAgAggTTTCAT
TAC
Simian virus 5 (SV5)/ Parainfluenza virus 5 (PIV5)
SV5-F CGTGGGGGATCCCTTCA AF052755
SV5-P 6-FAM-CCCACCAGCAGATA
CCAGTCAATTTGATC-BHQ-1
SV5-R CCACCTCTGGGTGATACAA
TGA
Genotyping (mitochondrial cytochrome b)
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L14724 CGAAGCTTGATATGAAAAA
CCATCGTTG
[84]
H15149 AACTGCAGCCCCTCAGAAT
GATATTTGTCCTCA
Legend: Human (h); bat (b); mouse (m); Forward primer (F, for, S); reverse primer
(R, rev, AS); probe(P, prb); β-Actin (ACTB); TATA box binding protein (TBP);
Simian virus 5 (SV 5).
2.1.11 Plasmids
Table 2.12: Plasmids for cloning and transfection
Name Type Source
pCAGGS-MCS Eukaryotic Vector S.B.
pRL-SV40 Eukaryotic Vector F.W.
p-125 Luc p55C1B-Luc T.F.
Legend: RL, Renilla-Luciferase; S.B., Prof. Stephan Becker, University of Marburg,
Department of Virology; F.W., Prof. Friedemann Weber, University Marburg, De-
partment of Virology; T.F., Prof. Takashi Fujita, Institute for Virus Research Kyoto
University.
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2.1.12 Software
Table 2.13: Computer programs
Name Description Version Source
BioEdit Sequence
Alignment
Editor
7.0.5.3 ©1997-2005 Tom Hall
DNASTAR
Lasergene 7
EditSeq,
SeqMan,
Protean
7.2.1 ©1989-2007 DNASTAR
Gene 5 1.04.5 ©2006-2007 BioTek
Instruments Inc
Oligo Calc http://www.basic.northwestern.
edu/biotools/oligocalc.htmL
AxioVision 4.8.1.0 ©2006-2009 Carl Zeiss
Imaging Solutions GmbH
2.2 Methods
2.2.1 Tissue culture conditions
Cell culture was performed under sterile conditions, which were accomplished by the
use of laminar flows and decontamination of surfaces and working equipment with
Incidin® (0.5% for BSL-2 or 3% for BSL-3 laboratories, respectively) or Hexaquart®
plus and Mycoplasma-OFF®. Cultivation of the cell lines listed in 2.6 was performed
at 37 °C and 5% CO2 with DMEM with 4.5 g/L Glucose supplemented with 1%
Penicillin/ Streptomycin 100 x concentrate (Penicillin 10,000 units/mL, Streptomy-
cin 10 mg/mL), 1% MEM NEAA 100 x concentrate, 1% Sodium Pyruvate 100 mM,
1% L-Glutamine 200 mM and 10% of FCS.
2.2.2 Harvesting, counting and seeding cells
In order to expand the cell lines, the old supernatant was discarded and washing of
the cells was performed by carefully adding 5 to 10 mL of PBS. Cells were detached
by incubating in trypsin solution for 5 to 10 minutes and when complete detachment
was observed, the cells were resuspended in DMEM.
All cells were commonly split in ratios 1:2 to 1:10 at 90% confluence. Cells were
counted with a Neubauer® cell counting chamber. The number of cells per mL was
calculated with the following equation:
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counted cells
number of chambers ∗ dilutionfactor ∗ 104 = cells/mL
Cell suspensions were usually adjusted to cell densities of 4 x 105 cells per mL.
2.2.3 Generation and immortalisation of bat cell cultures
Under the auspices of Ghana authorities bats were caught with mist nets, anaes-
thetized with a standard Ketamine/Xylazine mixture and euthanised to perform
organ preparations. Organs from E. helvum (embryo kidney and lung), E. buet-
tikoferi (kidney) and R. aegyptiacus (kidney) were cut into pieces, trypsinized and
cultured in DMEM medium as described previously [79]. Additionally, Imipenem
and Amphotericin B were added to minimize contamination risks. Immortalization
was done with the help of lentiviral transduction of the large T antigen of Simian
Virus (SV) 40 [208]. Immortalized cells were expanded and either stock-frozen or
processed further for subcloning. Three morphologically distinct cell clones were
then chosen for expansion and either further used in culture or frozen. All cell cul-
tures were genotyped by amplification of mitochondrial cytochrome b as previously
described using primers L14724 and H15149 [208, 67] and were controlled for myco-
plasma [190], SV5 (in-house assay, see 2.1.10), lyssaviruses [76] and filoviruses [141]
contaminations. In this study cell clones EidNi/41.3, EidNi/41.2, EpoNi/22.1 and
the mixed cell cultures EidNi/41 and RoNi/7 were used.
2.2.4 General procedure of tissue culture infections
The general infection procedure was similar in all experiments to obtain reproducible
results. The medium was discarded and the cells were inoculated with a virus stock
dilution (6 well: 1 mL; 12 well: 0.5 mL; 24 well: 0.25 mL; 96 well: 50-100 µL) for
one hour at 37°C. Thereafter, the supernatant was removed, cells were washed twice
with PBS and fresh medium was applied. The incubation time of the infected cell
differed between experiments and/or cells. Depending on the virus, experiments
were performed under either BSL-2 or -3 conditions. Inactivation of virus samples
were ensured by incubating in 8% formaldehyde (plaque assays) or incubation with
inactivating buffers (AVL (Viral RNA isolation kit), RLT (total RNA isolation kit)
or RIPA + SDS-loading buffer with in the following heat inactivation at 90°C for
10 minutes).
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2.2.5 Virus infection and titration
ONNV, SINV, CHIKV and RVFV 13 infections were performed at multiplicity of
infection (MOI) of 1 or 2.5 and 0.0025, respectively. The viruses were diluted in
serum-free medium OptiPRO. Cells were inoculated for 1 h and washed twice
after infection. Samples were taken at time points 0, 8 and 24 hours post infection
(hpi) or 4 and 10 hpi. Titrations of the viruses were performed by plaque assay as
previously described [79, 90]. Briefly, Vero E6 cells were seeded in 24-well plates at
a density of 4 x 105 cells per mL. Cells were inoculated with virus samples and after
1 h incubation the inoculum was removed. Subsequently the cells were washed with
PBS and 0.5 mL (per well) of an overlay solution of 2 x MEM, supplemented with
0.44% (w/v) NaHCO3, 20% FCS and 2% Penicillin/ Streptomycin, was mixed in a
1:1 ratio with 2.4% Avicel. After 48h of infection the overlay was discarded and cells
were stained with a 0.2% cristal violet and 20% EtOH containing solution. The virus
replication of RVFV 13 is proportional to the expression of the Renilla luciferase
expression and therefore to the chemiluminescence read-out measured with Multi-
Detections-Reader (Synergy 2, BioTek). The assay was performed as described
before [105] with the following minor modifications: Cells were seeded at a density
of 4 x 105 cells per mL and 20 µL of the cell lysate were added to the plate for
read-out. The calculation of the Relative Light Units (RLU) by dividing the mean
value of the sample of interest by the mean value of the negative virus control.
2.2.6 Virus inactivation by β-PL treatment
In case experiments were carried out with supernatants containing ONNV, SINV,
CHIKV or RVFV 13 virus was inactivated by β-PL treatment. The supernatants
were transferred to a 12-well plate and β-PL was added at a final concentration of
0.05% for RVFV 13 and 0.1% for the alphaviruses. The 12-well plate was wrapped in
a plastic bag and incubated for 16 h at 4°C. Subsequently the β-PL was inactivated
by hydrolysis, which was achieved by exposing the samples to 37°C for 2 h.
2.2.7 IFN induction by infection and transfection
The sensitivity of E. helvum cells to commonly used IFN inducers, was tested by
transfection of poly IC and infection with RVFV 13, which carries a Renilla luciferase
reporter gene instead of the non-structural protein NSs [105]. Both experiments were
performed in 6-well plates at a density of 4 x 105 cells per mL. The transfection
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of poly IC and the empty vector pCAGGS, which was used as negative control,
was executed with the Nanofectin® transfection reagent. To determine optimal
induction conditions 5, 2.5 and 1 µg poly IC per well were transfected to EidNi/41.3
cells according to the manufacturer´s instructions. The final IFN induction with
poly IC was done with 5 µg poly IC per well and 24 h after transfection cells were
lysed and total RNA was extracted (see 2.2.10.1). In a second approach, IFN-
induction was stimulated by infection with RVFV 13 with an MOI of 1 as described
in 2.2.4. After 24 h, all supernatants were harvested and treated with β-PL (see
2.2.6).
2.2.8 VSV-bioassay
A classical VSV bioassay was performed as described previously [200]. Briefly,
EidNi/41.3, EpoNi/22.1, MEF and MA104 cells were seeded in 12-well plates at
a density of 4 x 105 cells per mL. After 24 h the inactivated supernatants and a
pan-IFN-α (pan-IFN, a universal recombinant type I human IFN-α A/D hybrid)
standard dilution series was added to the respective cell lines. An internal standard
curve comprising five concentrations (0.5, 1, 10, 20 and 40 U/mL) of pan-IFN di-
luted in medium of mock treated cells was applied in every experiment. The external
pan-IFN standard curves for the EC50 calculation were performed in quadruplic-
ates and comprised pan-IFN concentrations between 0.25 and 150 U/mL diluted in
DMEM. 24 h post treatment, IFN containing supernatants were removed and cells
were washed with PBS. The cells were then infected with VSV at an MOI of 0.025.
After a 1 h virus adsorption, cells were washed and an Avicel overlay was added
as described in 2.2.5. As depicted in 3.1(in results) the optimal incubation time
varied between 24 and 48 h for the different cell lines. When the corresponding time
for incubation was achieved, the overlay was removed and the cells were fixed and
stained as described in 2.2.5.
2.2.9 Calculation of EC50 values and determination of
normalized IFN concentrations
The amount of plaques of the applied pan-IFN standard curves or of the test samples
was calculated in % (maximal plaque count from the negative control was set to
100%). The equation of the internal standard was used to calculate IFN amounts in
the samples (Table 3.2). EC50 values were defined as IFN concentrations which re-
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duces the number of plaques up to 50%. Thereafter, the values of IFN concentration
were multiplied by the dilution factors and figures were normalized to the amount
of IFN per mL. To define comparable, species-independent IFN concentrations the
calculated amount of IFN was divided by the EC50 of each internal standard curve.
Thus, the normalized amount of IFN could directly be compared.
n.o.p. relate to standard ∗ dilutionfactor ∗mLfactor = IFN/mL
IFN/ml− n.c.
EC50
= corr. IFN/mL
Legend: n.o.p. = number of plaques; n.c.= negative control; corr.= correlated.
2.2.10 Preparation and analyses of nucleic acids
2.2.10.1 Isolation of total RNA
Isolation of total RNA was the first step to allow investigations on changes in messen-
ger RNA (mRNA) abundance in cells upon infection or other stimuli. The RNeasy®
Mini kit, NucleoSpin® RNA II or the NucleoSpin® 8 RNA was used for total RNA
extractions. Basically, cells were treated with the RLT solution, which is a highly
denaturing guanidine isothiocyanate lysis buffer, and detached by pipetting a few
times. For final homogenisation the lysates were applied to the QIAshredder® spin
column system, before the RNA was applied to the silica gel-based membranes. The
extraction and washing steps that followed were performed as described in the man-
ufacturer's manual and the RNA elutions were done using 50 µL RNase-free water
pre-heated to 70°C. Nucleic acid concentrations were determined by spectrophoto-
metrical measurement and for final qRT-PCR assays adjusted to 80 ng/µL.
2.2.10.2 Isolation of viral RNA
Viral RNA (vRNA) was extracted from supernatants to determine viral replica-
tion based on real-time PCR. The extractions of vRNA was performed with the
QIAamp® Viral RNA Mini kit, NucleoSpin® RNA Virus or the NucleoSpin® 8
RNA Virus. The AVL buffer which is provided by the kit, is able to lyse viral
particles under denaturing conditions, thus inactivating infectious agents and RNases.
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Stabilizing carrier RNA was added to prevent vRNA from RNase degradation.
Thereafter, vRNA was applied to a silica gel-based membrane and procedure was
finished according to the manufacturer's manual. The AVE buffer was pre-heated
to 70°C and all samples were eluted in 50 µL. In this case the concentration of the
resulting vRNA was not measured due to the presence of carrier RNA but was either
used directly or stored at -80°C.
2.2.10.3 Spectrophotometric determination of nucleic acid concentrations
Nucleic acids are able to absorb monochromatic light at a specific wavelength (=
260 nm) which is based on their chemical structure. The phenomenon allows the
determination of the concentration of nucleic acids within a sample by photometric
measurements. Spectrophotometric determination of nucleic acid concentrations
were performed with a NanoDrop® and 1 µL of the corresponding diluting liquid
was used as a reference.
2.2.11 Polymerase chain reaction
The polymerase chain reaction (PCR) amplifies the nucleic acid sequence of interest
and thereby increases its amount up to detectable level. In brief, amplification of
the sequence of interest is achieved by cycles of denaturation of the double stranded
DNA, annealing of specific oligonucleotides (primers) flanking the area of interest
and elongation of the 3'-hydroxy moiety of the primers with the help of a thermo-
stable DNA-dependent DNA polymerase of bacterial origin (Thermus aquaticus).
2.2.11.1 Quantitative real-time RT-PCR for detection of IFN, MxA, ISG56
and TBP mRNA
The addition of a fluorescently labelled probe to the PCR enables real-time mon-
itoring of the exponential amplification. Exponential amplification above the back-
ground fluorescence signal determines the crossing point (cp). The measured cp
values can be used for relative or absolute quantification mRNA concentrations.
IFN, MxA and ISG56 as well as TBP mRNA abundance was quantified from total
RNAs.
PCR assays were performed as one-step reverse transcription PCRs, using the
SuperScript® III One-Step RT-PCR System with Platinum Taq® DNA polymerase.
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The reaction volume of the amplications was 12.5 µL, including 6.25 µL 2 RXN-
buffer, 0.25 µL one-step RT-PCR kit enzyme mix (both provided by the kit), 400 nM
of each primer, 200 nM probe, 1 µg BSA, Ampuwa® water and 1 µL sample RNA.
The species-specific primers and probes are listed in 2.1.10. The reverse transcriptase
reaction was performed for 15 minutes at 55°C. The initial denaturation was done
for 2 minutes at 95°C. In the following 45 cycles of 15 seconds denaturation at 95°C
and 30 seconds annealing/elongation at 58°C were performed. To determine the
fold-induction of the different target genes (IFN, MxA, ISG56) the 2−44Ct method
was applied with TBP as housekeeping gene [119].
2.2.11.2 Real-time RT-PCR for detection of ONNV, SINV and CHIKV
The quantification of viral genome equivalents from tissue culture supernatants was
performed with the isolated vRNA as described previously (see 2.2.10.2) and tested
by one-step RT-PCR with reactions set up as in 2.2.11.1.
For the quantification of ONNV, SINV and CHIKV genome equivalents (GE) the
dilution end-point were defined as one PCR unit. Log PCR units per mL for each
experimental sample were calculated from the linear equations of the dilution series
as described [144].
2.2.12 Eukaryotic protein isolation
After the induction of ISGs by either RVFV 13 or poly IC, total protein extraction
was performed by lysis of cells with RIPA buffer supplemented with DTT, Ben-
zonase, and proteinase inhibitor III (PI-III) before use. After the supernatant was
discarded and the cells were washed with PBS, 100 µl of the RIPA-based solution
was added to the 6 well. Homogenisation was achieved by scraping off the monolayer
and repetitive pipetting, which was followed by an incubation of 20 minutes on ice
(4°C). Samples were either stored at -80°C or directly analysed by SDS-PAGE and
Western blot analysis.
2.2.13 SDS-PAGE and Western blot analysis
Proteins can be detected with specific antibodies by Western blot analysis. Here, the
expression of the ISGs p56 and MxA proteins after viral infection with RVFV 13 or
ONNV, SINV as well as CHIKV were compared to expression levels of non-treated
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cells. Protein samples were diluted 1:10 with RIPA buffer and 15 µl of the dilution
was supplemented with 5 µl 4 x loading buffer (NuPage®) containing β-ME for
protein denaturation. The mixture was heated to 90°C for 10 minutes. 10 µl of the
samples and 5 µl marker (Page Ruler® Prestained Protein ladder) were loaded on a
10% SDS polyacrylamide gel electrophoresis (PAGE) (see Tab. 2.10). The intrinsic
charge of the polypeptides is overcome by SDS binding, resulting in polypeptides
being only negatively charged. They can subsequently be separated by an electric
field according to their molecular weight.
Table 2.14: Compounding of a 10% SDS PAGE components stacking gel separation gel
ingredients separation gel stacking gel
30% acrylamide 3.33 mL 0.5 mL
1.875 M Tris (pH 8.8) 2.0 mL
0.6 M Tris (pH 6.8) 0.6 mL
Ampuwa® water 4.51 mL 1.85 mL
10% SDS 100 µL 30 µL
10% APS 50 µL 15 µL
TEMED 10 µL 3 µL
SDS-PAGE were run at 80 volts until the proteins reached the separation gel.
The voltage was then adjusted from to 100 volts. The SDS-PAGE was followed by
semi-dry blotting with a transfer of the proteins to a membrane of polyvinyliden
uorid (PVDF) with a pore diameter of 0.45 µm. Activation of the membrane with
methanol enabled immobilization of the proteins by hydrophobic interactions. The
transfer of the proteins from the gel to the PVDF membrane was achieved by an
electric field of 200 mA per membrane and with a maximum of 25 volts for 1.5 h.
After the proteins were transferred to the membrane, unspecific antibody-binding
during the immuno detection was limited by incubating the membrane in blocking
buffer (5% milk powder diluted in PBS-Tween (PBS-T; 0.1% Tween20)) for at least
one hour. Specific proteins were detected by exposing the membrane to the primary
antibody. In this case mouse anti-MxA, p56 and actin, at a dilution of 1:5000
in PBS-T containing 1% dry milk, for 1 h respectively. To minimize unspecific
antibody binding five washing steps with PBS-T of 5 minutes were performed before
the membrane was incubated with the secondary antibody (goat-anti-mouse diluted
1:20000 in 1% milk powder PBS-T) for 45 minutes. The membrane was washed five
times with PBS-T to remove residual antibodies for five minutes. The linkage of the
secondary antibody to a horseradish peroxidase (HRP) enabled detection of bound
proteins by chemiluminescence. 150 µl SuperSignal R Femto Maximum Sensitivity
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substrate was added to the membrane and incubated for 5 minutes in the dark. The
chemiluminescent signals were detected by the FusionFx7 from PeqLab.
2.2.14 Immunofluorescence
In cooperation with the company EUROIMMUN (EU38, Lubeck), a mosaic im-
munofluorescence chip harbouring cells infected with 15 various human pathogenic
viruses was used. VEEV and CHIKV infected cells represented New and Old World
alphaviruses. Each slide contained acetone fixed and γ-radiated infected cell with
an approximate infection of 30 to 50%. The cells were initially treated with diluted
bat sera (1:40). Thereby allowing the bat antibodies to bind to viral antigens that
were present in infected cells. Next, the bound bat antibodies were recognized by
an goat anti-bat immunoglobin (Ig) (Bethyl Laboratories, Montgomery, TX, USA)
directed to the constant region of the bat antibody. To detect positive sera via IF,
the following antibody was a donkey anti-goat Ig conjugated to a cyanine 3 (Cy 3)
(Dianova, Hamburg) or to fluorescein isothiocyanate (FITC). Final observation was
performed with the Fluorescence Axio Imager M1® microscope from ZEISS.
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Technical preliminary work
As a technical prerequisite bat cell cultures of African fruit bats like E. helvum, R.
aegyptiacus and Epo. buettikoferi had be to established. Secondly the established
VSV-bioassay was optimized to enable the comparison of secreted bioactive IFN
after infection with the same virus. The IFN response, - induction, - secretion and -
signalling was investigated and compared to mammalian model cell lines like MEF
and MA104.
3.1 Generation of cell cultures
3.1.1 Immortalised and subcloned bat cell lines
E. helvum, R. aegyptiacus and Epo. buettikoferi belong to the Old World fru-
givorous/ nectarivorous bats or flying foxes (Pteropodidae; formerly classified as
Megachiroptera). Whereas E. helvum was shown to harbour Henipa-like viruses
[41], R. aegyptiacus is a known reservoir for the Marburg virus [199, 200, 192].
Epo. buettikoferi was found to carry Lagos bat virus (LBV) [75]. Bats carry these
pathogenic viruses without showing overt clinical symptoms implying specific im-
munological defence mechanisms. Cell culture systems as a basic tool in molecular
virology could help to identify cellular mechanisms. So far only for R. aegyptiacus
and Tadarida brasiliensis cell cultures are commercially available. In cooperation
with M. A. Mueller E. helvum and Epo. buettikoferi bats roosting in Kumasi, Ghana,
were investigated shortly before the parturition season in 2009. Pregnant females
were euthanised by injection of Ketamine/Xylazine according to approved proto-
cols, under a license from the veterinary services and the Ministry of Food and
Agriculture, Accra, Ghana. Primary cell cultures from embryonic kidney tissue of
all three bat species were generated at the Kumasi Collaborative Center for Research
in Tropical Medicine, Kumasi (Figure 3.1). Immortalisation of the cells was per-
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formed by lentiviral transduction of the SV40 large T antigen [79]. While primary
cells could only be passaged twice, immortalised cells could be passaged continu-
ously (> 30 passages). Clonal cell lines were achieved by end point dilution out of
the second passage. In Figure 3.1 cell lines of EidNi/41.3 for in-depth character-
isation are shown. To exclude subclone specific differences, two additional clonal
cell lines from the same preparation (EidNi/41.1 and EidNi/41.2) and one mixed
culture (EidNi/41) were included in some experiments. The different subclones and
the mixed culture showed the same phenotype (Figure 3.1). In addition kidney cell
cultures (4th passage) from adult R. aegyptiacus (RoNi/7) and Epo. buettikoferi
(EpoNi/22.1) from bats were prepared as described for EidNi/41.3 cell lines to in-
vestigate putative differences between related frugivorous bats. Genotyping of all
bat cell cultures was performed by amplifying the mitochondrial cytochrome b frag-
ments [84] followed by a BLAST analysis.
Figure 3.1: Generation of immortalized bat cells.
Example of primary bat cell cultures which were generated from an embryonic kidney
of E. helvum. Cell cultures were immortalized by lentiviral transduction of SV40
large T antigen. Three subclonal cell lines (EidNi/41.1, 41.2 and 41.3) were prepared
from a mixed culture (EidNi/41) by end point dilution plating. Bar indicates 20 µm.
3.1.2 IFN induction of established bat cell cultures
The generated cell cultures were used to study intracellular signalling cascades in
particular the IFN response. IFN induction and secretion could previously be shown
for primary bat cells of the Pteropus species [208, 187, 32, 223]. Immortalisation
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of cells can result in dysfunctional signalling pathways by damaged cytokine genes.
Therefore the reactivity of EidNi/41.3 to IFN stimuli was tested. Two methods were
chosen to analyse the IFN induction in EidNi/41.3 cells. First, cells were transfected
with three different concentrations of poly IC, which is a synthetic analogue of
dsRNA [95]. In a second approach, cells were infected with RVFV 13 which is
lacking the NSs protein, its main IFN antagonist. It was previously shown that this
virus induces IFN response in epithelial cells [105, 18]. After IFN induction by these
methods, the upregulation of IFN mRNA was examined by real-time RT-PCR.
For the applied prototype cell cultures (MA104, MEF) specific RT-PCRs were
already available [80]. To enable comparison of mRNA expression levels between
bat and other mammalian cell lines, specific quantitative RT-PCR for bat cells had
to be designed. In cooperation with Daniel Ritz (Institute of Virology, Bonn) the
IFN beta gene was amplified by nested RT-PCR from cell cultures of a phylogen-
etically representative range of bats differing in main diet and hunting strategies
including the insectivorous M. daubentonii, Pipistrellus spec. (Vespertilionidae),
H. cf. caffer/ruber (Hipposideridae) and R. cf. landeri (Rhinolophidae) as well as
the frugivorous/nectarivorous bats R. aegyptiacus and E. helvum (Pteropodidae)
(Figure 3.2a). RT-PCR primers were designed after alignments of available IFN-β
genes from horses, swine, cattle, humans, mice and rats (Table 2.1.10). A conserved
region among bats was identified and used to design forward and reverse primers
as well as probes (Figure 3.2b) for the quantitative real-time RT-PCR analysis by
Primer Express 3.0.
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(a)
(b)
(c)
Figure 3.2: Design of bat-specific RT-PCRs and IFN response of infected bat cells.
(a) Phylogenetic relationships of different selected bat species for the generation of target
gene sequences (adapted from [89]). (b) For the IFN-β gene four species were selected.
Alignment of bat IFN-β genes (E. helvum, M. daubentonii, R.cf. landeri and R. aegyp-
tiacus) and positions of primers and probe for a pan-bat real-time RT-PCR. (c) Sensitivity
to different amounts of commonly used IFN inductors like poly IC or RVFV 13. Cells were
transfected with poly IC at 3 different concentrations or infected with RVFV 13 at three
different MOI´s. 24 hpi cells were lysed and IFN mRNA was measured with RT-PCR.
In parallel TBP mRNA levels were determined as a reference for cellular gene expression.
Experiments were performed in triplicates.
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Next, the designed RT-PCR was evaluated by applying two methods to induce
IFN response. IFN mRNA levels were detected after treatment with three differ-
ent concentrations of poly IC and RVFV 13. The bat specific RT-PCR assay was
sensitive for the IFN-β mRNA of EidNi/41.3 cells and detected a high expression
(>1000-fold) of the IFN-β gene upon stimulation (Figure 3.2c). IFN induction by
poly IC was dose-dependent. The highest expression levels of IFN mRNA were
found after stimulation with 5 µg poly IC (6150-fold) per well of a 6 well plate, fol-
lowed by a lower stimulation observed efficiency for 2.5 µg poly IC (1672-fold). This
result was also found after stimulation with RVFV 13 at MOIs 5 and 1 (5700- and
2180-fold) . To choose comparable conditions for all cell lines and ensure equally
strong IFN induction poly IC was used at a concentration of 5 µg per well of a 6 well
plate and RVFV 13 was applied at an MOI of 1 in the following experiments.
3.1.3 Sensitivity of different bat and reference cell lines to
IFN inductors
Next the IFN response between bat cells and other mammalian reference cells was
compared with the optimized stimulation conditions. The bat cell line, EpoNi/22.1,
was included in the experiments testing the sensitivity of the different cell lines
to commonly used IFN stimulating factors. This cell line was generated from the
bat species Epo. buettikoferi , which was together with E. helvum and other species
identified to carry LBV [75]. The IFN response was induced by poly IC and RVFV 13
treatment in EidNi/41.3, EpoNi/22.1, MEF and MA104 cell lines under conditions
optimized in EidNi/41.3 as described in paragraph 3.1.2. 24 h post transfection
with poly IC, IFN-β mRNA transcription levels were measured by species-specific
RT-PCR assay and compared to the transcription levels of the house keeping gene
TBP. For all cell lines a 100-fold increase of IFN-β was observed. Upon RVFV 13
infection the bat cell lines showed a stronger IFN induction compared to MEF and
MA104 cells (Figure 3.3a).
50
3 Results
(a) (b)
Figure 3.3: IFN induction in bat cell lines.
(a) IFN-β mRNA transcription was induced by either RVFV 13 infection (MOI 1)
or poly IC transfection (5µg per 6 well). IFN-β and TBP mRNA was quantified by
species-specific real-time RT-PCR assays. The fold induction was calculated with the
2−44Ctmethod. (b) Replication of RVFV 13 expressing a Renilla luciferase in various cell
lines (EidNi/41.3, MEF, MA104 and as reference Vero cells at different MOIs. Cells were
infected at different ten-fold diluted MOIs (7.5 until 0.000075) and lysed 24 hpi with Renilla
lysis buffer (Promega). Replication was detected by Renilla luciferase read-out. Experi-
ments were performed in duplicates. Highest replication was found in Vero cells followed
by EidNi/41.3, MEF, MA104 (between 10 to 100-fold less compared to Vero cells).
To exclude that differences in IFN induction were due to variable replication a
selected bat, a primate and the murine cell line together with a reference cell line
(Vero) were infected with RVFV 13 of different MOIs. Since this virus has its
IFN antagonist replaced by the Renilla luciferase gene, virus replication could be
correlated to the luciferase expression [105]. As depicted in Figure 3.3b, all cell lines
were efficiently infectable by RVFV 13. The replication correlated with the virus
concentration that was used (Figure 3.3b).
It was concluded that both generated bat cell lines EidNi/41.3 and EpoNi/22.1
were able to react to natural and artificial IFN stimuli and that the pathways were
not negatively affected by the immortalisation. The IFN-β transcription was equal
or even stronger in comparison to MEF and MA104 cells.
3.2 VSV-bioassay
IFN-β mRNA transcription was a first indicator for type I IFN response. To verify
that upregulated mRNA led to measurable amounts of type I IFN proteins, it was
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tested whether EidNi/41.3 and EpoNi/22.1 cells were able to produce and secrete
effective doses of type I IFN. Therefore it was necessary to compare and calibrate
species-specific IFN secretion between primate, rodent, and bat cells, using an ap-
propriate experimental model. To achieve this, a VSV-based IFN bioassay was
established. A VSV-bioassay was chosen for two reasons i) the virus is known to
enter almost every cell line [29] causing cytopathogenic effects and ii) the virus is
highly sensitive to IFN pretreatment of the cells [15]. The IFN induced antiviral
state of the cells results in dose-dependent plaque reduction. The optimal conditions
for the VSV-bioassay were calibrated for all cell lines.
3.2.1 Optimisation of experimental conditions
First approaches for the development of the VSV-bioassay were focused on handling
and proceeding. As shown in Figure 3.4a three various well formats were tested (6,
12 and 24 well). Plaque formation in the 6 well format was detected, but for practical
handling reasons this format was excluded. In the 12 well format plaque formation
was sufficient and the sample volume was reduced by half. In the 24 well format
the number of plaques was too small to generate a standard curve. Therefore in the
following experiments the 12 well format was chosen. To gain a countable number
of plaques, virus concentration and time of incubation after infection needed to be
optimized. All cell lines were infected with three different MOI´s and the incubation
time was varied from 24 to 72 h. In Figure 3.4 an example of the optimization for
MA104 cells is given. In general, a correlation between plaque size and incubation
time was observed. Cells treated with an MOI of 0.125 showed numerous plaques
after 24 h incubation which resulted in complete destruction of the cell monolayer
after longer incubation times. The second MOI tested was 0.025 and resulted in a
countable number of plaques after 24 hpi, 48 and 72 h was found to be too long
for proper plaque counting. For the third virus concentration optimal incubation
time was identified to be 48 hpi. As depicted for MA104, both virus concentrations
(MOI 0.025 and 0.0125) were possible. After infection with an MOI of 0.025 the op-
timal time of incubation was 24 h, whereas infection with an MOI of 0.0125 optimal
plaque formation was achieved after 48 h. To accelerate experimentation MOI 0.025
was further applied. Incubation was increased to 30 hpi to allow formation of easily
countable plaques.
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(a) (b)
Figure 3.4: Optimisation of VSV-bioassay.
(a) R. aegyptiacus kidney cells were seeded in 6, 12 and 24 well plates at a density of 4 x
105 cells per mL. After 24 h cells were infected with VSV at an MOI of 0.025. After 1h of
incubation supernatants were discarded, cells were washed and overlayed with Avicel. Two
days post infection overlay was removed, the cells were fixed and staining was performed
with crystal violet solution. Optimal plaque performing conditions for creation of standards
were found with the 12 well format. (b) For each cell line virus concentration and incubation
time was optimized. Here the example of three virus dilutions and different incubation time
points for MA104 cells is shown.
Optimization of virus dilution and incubation time was performed for a number of
cell lines that are listed in table 3.1. For most tested cell lines MOI 0.025 was found
to be optimal with an incubation time of 24 to 48 h. VSV was not able to infect
the HeLa cell line and 293lp cells showed various plaque formations after infection,
which made these cells not applicable for this assay. For further experiments the
cell lines EidNi/41.3, EpoNi/22.1, MEF and MA104 were selected.
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Table 3.1: Overview of tested cell lines for VSV-bioassay
Cell line Species VSV
susceptibility
IFN
induction
Plaque
forma-
tion
Time of
incubation
MOI 0.025 in h
293 lp Human yes NA not stable assay not applied
A549 Human yes yes yes 24
HeLa Human no NA no -
Hep2 Human yes yes yes 48
MA104 Primate yes yes yes 30
MEF Rodent yes yes yes 48
RoNi/7.1 Bat yes yes yes 48
EidNi/41.3 Bat yes yes yes 48
EpoNi/22.1 Bat yes yes yes 24
Legend: NA = not applicable
3.2.2 VSV plaque morphology and sensitivity to pan-IFN
For the selected cell lines the variable VSV plaque morphology was documented as
shown in Figure 3.5a. For calibration of IFN secretion across species, cells were
incubated with a dilution series of pan-species IFN. The optimal outcome would
show complete plaque reduction with highest concentrations of pan-IFN and con-
tinuously increasing numbers of plaques at decreasing pan-IFN concentrations. Due
to species-specific IFN α/β receptor molecules the sensitivity to pan-IFN was ex-
pected to vary between all cell lines. Thus it was crucial to optimize the range of
the dilution series for each cell line. In Figure 3.5b the dilution series for EidNi/41.3
is shown. This data were the basis for the determination of individual EC50 values.
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(a)
(b)
Figure 3.5: IFN quantification and calibration by VSV-bioassay.
(a) VSV plaque morphology was analysed for the bat cell lines EidNi/41.3 and EpoNi/22.1,
a rodent cell line, MEF, and a primate cell line, MA104.(b) For the VSV-bioassay standard
EidNi/41.3 cells were pre-incubated with various amounts (units per mL; U/mL) of pan-
species IFN (pan-IFN). Cells were fixed 24 h after treatment, stained and plaques were
counted to estimate the correlation between the amount of pan-IFN and plaques. NC,
negative control and PC, positive control.
3.2.3 Generation of standard curves and calculation of EC50
values
After determining the optimal range of pan-IFN treatment standard curves had
to be generated for EC50 calculations. The EC50 is the effective dose of pan-IFN
to achieve a 50% plaque reduction. All cell lines were incubated with dilution
gradients within the determined optimal range of recombinant pan-IFN. The number
of plaques expressed in percentage was correlated to the dilution series of pan-IFN
concentration in U per mL (Table 3.2).
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Table 3.2: Calculation of the standards
Cell line rIFN U/well n.o.p. in % equation
EidNi/41.3
15 0
10 0
6 22,56 y = -28,75ln(x) + 78,668
2 78,04
1 95,73
0,25 100
EpoNi/22.1
30 1,91
25 3,02
20 7,23 y = -33,19ln(x) + 121,06
10 66,73
5 98,47
1 100
MEF
15 0
10 5,1724
5 17,2414 y = -31,65ln(x) + 79,861
4 40,2299
1 85,0575
0,5 100
MA104
50 0
25 3,45 y = -20,02ln(x) + 84,42
10 53,65
5 67,68
1 88,41
0,25 100
Legend: n.o.p. = number of plaques
Different sensitivities to pan-IFN among the various cell lines were observed and
EC50 values ranged between 2.6 and 11.2 U/mL (Table 3.3). At least three pan-
IFN concentrations from these defined species-specific standards had be to included
in every VSV bioassay that followed. EidNi/41.3 had an EC50 value of 3.4 while
EpoNi/22.1 showed an EC50 value of 11.2 (Table 3.3).
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Figure 3.6: Standard curves and EC50 values for VSV-bioassay.
With pan-IFN dilution series standard correlations between number of plaques as a per-
centage and pan-IFN U in mL were achieved. EC50values indicate the amount of IFN to
reduce the number of plaques to 50 percent. This factor was determined to correlate IFN
concentrations between different cell lines.
The sensitivity to pan-species IFN was independent of origin or relation of the
cell lines (MEF < EidNi/41.3 < MA104 < EpoNi/22.1). All determined IFN con-
centrations in the following experiments were normalized with the determined EC50
values. This enabled the comparison of secreted IFN concentrations between differ-
ent cell lines from variable species independently from their IFN receptors and the
differential sensitivity to the pan-species IFN.
Table 3.3: Definition of EC50 values
Cell line EidNi/41.3 EpoNi/22.1 MEF MA104
EC50
(U/mL)
3.4 11.2 2.6 9.3
3.2.4 Comparison of IFN secretion
With the help of the established VSV-bioassay species-specific secreted bioactive
IFN could be measured. As described in chapter 3.2.3 infection with RVFV 13 and
transduction with poly IC led to measurable IFN induction on mRNA level (Figure
3.7a). Supernatants from the same cells were now used to measure secreted IFN.
In accordance with increased IFN mRNA transcription, elevated levels of secreted
IFN were detected for all cell lines starting at a 1,000 fold increase (Figure 3.7a). In
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EidNi/41.3 cells the induction with both IFN stimulating factors led to an 100,000
fold increase in secreted IFN. In accordance with the increased mRNA levels (Fig-
ure 3.3), EpoNi/22.1 cells showed stronger IFN secretion after RVFV 13 treatment
compared to the IFN stimulation with poly IC. Both stimuli induced IFN gene
expression as well as secretion (Figure 3.7b).
(a) (b)
Figure 3.7: Bat cells produce high levels of secreted IFN.
(a) Cells were infected with RVFV 13 or transfected with poly IC as described before. With
the help of the VSV-bioassay secreted IFN was measured. Each cell line was incubated for
24 h with IFN-containing supernatants (β-PL inactivated) and with pan-IFN standards
diluted in medium from untreated control cells. IFN concentrations were normalized with
the help of EC50 values as described in the methods section. (b) IFN-β mRNA transcription
was induced by either RVFV 13 infection (MOI 1) or poly IC transfection (5µg per 6 well).
IFN-β and TBP mRNA was quantified by species-specific real-time RT-PCR assays. The
fold induction was calculated with the 2−44Ctmethod.
Except for cell line EidNi/41.3, RVFV 13 led to higher IFN secretions. Most ap-
plied cell lines thus showed a higher sensitivity to the replicating virus as a ´natural`
stimulus (Figure 3.7a). In conclusion, EidNi/41.3 and EpoNi/22.1 cell lines were
able to express IFN mRNA after induction with natural and artificial stimuli, to
secrete measurable, active type I IFN protein leading to an antiviral state and to
produce comparable and higher amounts like MEF and MA104 cell lines.
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Overview
Bats harbour a multitude of human pathogenic viruses including arboviruses like
VEEV, CHIKV and SINV [24]. Their role in the arboviral life cycle has not been
investigated yet. Little is known about virus host interaction, particularly host
specific defence mechanisms. In this study the prevalence of arboviruses in bats with
focus on Togaviridae (New and Old World viruses) was analysed by a serological
assay. Additionally first insights into the IFN response mechanisms of bat cells were
gained by newly developed in vitro tools.
3.3 Serological survey of Alphaviruses in bats
A variety of alphaviruses have been detected or isolated from different bat species
[24]. So far it is unclear which role bats play in the alphavirus life cycle. Since
bats harbour parasites and can be bitten by mosquitoes it can be assumed that
they serve as an intermediate host. In order to get insights into the prevalence of
alphaviruses in bats we conducted a serological survey. The map in Figure 3.8 shows
origin countries of bat sera, namely Germany, Ghana, Gabon and Panama, which
were analysed for alphavirus antibody prevalence (Figure 3.8).
Figure 3.8: Distribution of analysed samples in the world.
Various bat species were captured with mist nets. Blood and stool samples were taken
and frozen until further analysis. Species were determined by field ecologists. The samples
used in this study were collected in Germany, Ghana, Gabon and Panama. The countries
of origin are marked in red.
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In each country an average of four species was collected. Blood, faecal and parasite
samples were taken and wing size and bone length were measured by field biologists.
In this study only serum samples were included. In cooperation with M. A. Mueller
(Institute of Virology, Bonn), 1136 sera from 16 bat species were analysed for anti-
body reactivity with alphavirus antigen. Bat sera were screened for cross reactive
antibodies by IF assay as described in chapter 2.2.14. The IF slides carried either
VEEV or CHIKV infected Vero cells. Only 30 to 50% of the cells were infected in
order to guarantee non-infected cells to be present as a negative control. In Figure
3.9 an example of positive and negative tested bat sera is given (Figure 3.9).
Figure 3.9: Immunological analysis of bat sera.
Bat sera were exposed to VEEV or CHIKV infected Vero cells. Eidolon helvum (E.h.)
(GH85), Epomops franqueti (E.f.) (GB3520), Rousettus aegyptiacus (R.a.) (GB1558) and
Hypsignathus monstrosus (H.m.) (CHA431) were found to have cross reactive antibodies
with VEEV and CHIKV antigens.
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Cross reactions with VEEV and CHIKV antigens were found in E. helvum, Epo.
franqueti, R. aegyptiacus and H. monstrosus bat sera. All four species with higher
prevalence belonged to frugivorous bat species. These cross reactions with VEEV
antigens are consistent with earlier findings of VEEV detection in neotropical bats
in Mexico, 1970 [19, 31]. In total 5% of all tested bat species were found seropositive
(Table 3.4).
Table 3.4: Bat sera tested for alphavirus reactivity from different species and locations
Bat species Togaviridae
Old World fruit
bats
Location Sera
tested
VEEV
Positive n
(%)
CHIKV
Eidolon helvum Ghana 167 1 (0.6) 8.0 (4.8)
Epomops franqueti Gabon 99 13 (13.1) 13 (13.1)
Hypsignathus
monstrosus
Gabon 94 11 (11.7) 14 (14.9)
Micropterus
pusillus
Gabon 100 3 (3.0) 3 (3.0)
Myonycteris
troquata
Gabon 100 18 (18.0) 16 (16.0)
Rousettus
aegyptiacus
Gabon 197 2 (1.0) 4 (2.0)
Insect bats
Coleura afra Gabon 14 0 (0.0) 0 (0.0)
Hipposideros caffer Gabon 48 0 (0.0) 2 (4.2)
Hipposideros gigas Gabon 129 1 (0.8) 1 (0.8)
Miniopterus
inflatus
Gabon 51 1(2) 0 (0.0)
Myotis dasycneme Germany 26 0 (0.0) 0 (0.0)
Myotis daubentonii Germany 28 0 (0.0) 0 (0.0)
Nyctalus noctula Germany 24 0 (0.0) 0 (0.0)
Rhinolophus spec. Gabon 16 0 (0.0) 1 (6.3)
Neurotropical
bats
Artibeus
jamaicensis
Panama 28 1 (3.6) 2 (7.1)
Artibeus lituratus Panama 15 0 (0.0) 0 (0.0)
Percentage
positive (%)
4.5 5.6
No. total sera
positive (n)
51 64
Total sera tested 1136
Antibody reactivity was 10-fold higher in fruit bats compared to insectivorous
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bats. Highest seroprevalence was detected inMyonycteris troquata (20%) and lowest
prevalence was found in Miniopterus inflatus (2%). The geographical distribution
of positive bats could be correlated with the abundance of the arbovirus vector-
the mosquito species Aedes aegypti or Anopheles gambiae. These mosquitoes are
mainly found in tropical regions. All bat serum specimens collected in Germany were
negative. The neotropical bats showed an abundance of approximately 5%, only in
A. jamaicensis. Interestingly, VEEV antigen reactive sera were found to the same
amount as CHIKV, although VEEV belongs to the New World alphaviruses spread
in Central- and South America. Likewise CHIKV antibodies were found in sera from
neotropical bats. A general cross-reactivity of sera with those related antigens can
be excluded as several sera reacted exclusively with only one viral antigen. These
findings could be explained by cross reactivity with closely related viruses located
in Africa for VEEV and in Central America for CHIKV. As alphaviruses can infect
bats and induce sero conversion the generated cell cultures were applied for further
investigations.
3.4 IFN response after ONNV infection in
EidNi/41.3, EpoNi/22.1, MEF and MA104 cell
lines
The Old World alphavirus ONNV was chosen since alphaviruses have been previ-
ously detected in bats [19, 31] and induce IFN response [158]. Alphaviruses avoid
the antiviral response of cells by initiating a cellular translational shutoff, while the
viral translation remains unaffected [158, 215, 23]. Here, it was analysed whether bat
cells show the same IFN response to alphavirus infection compared to mammalian
reference cell lines MEF and MA104.
3.4.1 ONNV replication
The following experimental considerations were taken into account for infection stud-
ies with ONNV. First a high MOI of 2.5 was chosen to ensure a synchronized in-
fection. In addition, incubation times of 0 and 24 hpi were selected to guarantee
measurable amounts of increased IFN in supernatant but only slight cytopathic ef-
fects (CPE) for all cell lines. Finally, supernatants and cells were harvested at the
same time to simultaneously measure genome equivalents (GE) per plaque forming
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unit (PFU) and mRNA expression levels as well as secreted IFN protein in the same
sample. Virus growth was determined by an ONNV-specific real-time RT-PCR (Fig-
ure 3.10a) and by titration of viral particles in supernatants 24 hpi (Figure 3.10b).
Virus mRNA and infectious virus were detected in all cell lines. A 1,000-fold in-
crease of GE was detected for infectious virus formation after 24 hpi. However, newly
synthesized RNA genome could be degraded, thereby leading to positive RT-PCR
values but no infectious virus particles. The specific infectivity, expressed as PFU
per genome equivalent (PCR units), was used to evaluate the quality of replication.
A value expressed as specific infectivity, indicated a good quality of replication. All
cell cultures showed a high level of replication and highly comparable results (Figure
3.10c).
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(a) (b)
(c)
Figure 3.10: ONNV replication in different mammalian cells using a high MOI.
(a) For a synchronized infection cells were inoculated with ONNV at an MOI of 2.5 and su-
pernatants were harvested at 0, 8 and 24 hpi. After viral RNA isolation the concentration
was measured by ONNV specific real-time RT-PCR assay (triplicates). ONNV PCR units
(U) per mL were determined. The dilution end-point was defined as one PCR unit. Virus
replication could be detected in all cell lines. The increase of genome equivalents per mL
were approximately 1,000-fold after 24 hpi. (b) Titration of ONNV 24 hpi in supernatants.
In all cells viral particles were formed. (c) The specific infectivity was estimated by calcu-
lating the ratio between PFU and ONNV PCR U. In all cell lines the specific infectivity
was comparable.
3.4.2 IFN induction after ONNV infection
After confirming that all cells were efficiently infected and to similar levels the IFN
responses of the different cell lines were analysed. IFN induction was determined
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by correlation of IFN mRNA levels to expression levels of the housekeeping gene
TBP. Samples were taken at 0, 24 hpi and, additionally, at 8 hpi since the mRNA
transcription levels are prone to variation. In all cell lines an increase of IFN mRNA
transcription was detectable and ranged between 7.3 to 8.0 logs (Figure3.11a).
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(a) (b)
(c) (d)
(e)
Figure 3.11: IFN-β mRNA induction but IFN protein decrease in all mammalian cells
upon ONNV infection.
(a) Mean fold change in IFN-β gene expression detected by species-specific real-time RT-
PCR 0, 8 and 24 hpi with ONNV. (b) The induced IFN-β mRNA levels were correlated
to the amount of relative ONNV genome equivalents in PCR units per mL.
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(c) At 24 hpi the increase of secreted IFN was correlated to ONNV plaque forming units
indicating that higher virus titres led to a decreased amount of IFN in the supernatants.
(d) Comparison of secreted IFN protein to IFN-β mRNA 24 hpi with ONNV, RVFV 13
infection and poly IC transfection. ONNV replication was related to IFN protein reduction.
The IFN induction was directly compared to ONNV infection. While no induction
of IFN mRNA was detectable at 8 hpi, ONNV replication clearly induced IFN
mRNA expression by 24 hpi for all cell lines (Figure 3.11b). The increased viral
titers corresponded to lower amounts of secreted IFN protein after 24 hpi (Figure
3.11c). EidNi/41.3 cells showed highest levels of secreted IFN but lowest level of
infectious particles, indicating that virus growth was limited in response to IFN. To
differentiate whether virus control correlated with levels of secreted IFN or merely
with the induction of genes under control of the IFN promoter, the ratios of secreted
IFN versus IFN mRNA were determined in all cell lines. The ratios of secreted IFN
versus IFN mRNA after stimulation by RVFV 13 or poly IC were in all cell lines
comparable. In contrast, in all cell lines infected with ONNV the relative levels
of secreted IFN were clearly reduced, while overall IFN mRNA induction was less
affected (Figure 3.11d). This effect was independent from the cell species indicat-
ing a ONNV-specific IFN protein reduction. To exclude cell clone specific effects,
EidNi/41.2 and the mixed culture EidNi/41 were additionally analysed. These cell
lines showed the same reduction of relative IFN secretion upon ONNV infection
(Figure 3.11e). Similar effects were also detected in a mixed culture generated from
the related flying fox R. aegyptiacus (RoNi/7). The human cell line A549 showed
a stronger reduction on IFN secretion than MEF and MA104 cell lines in similar
experiments (Figure 3.11e).
3.4.3 mRNA levels of IFN and ISGs
Alphaviruses were shown to induce transcriptional shutoff affecting mainly the cel-
lular but not the viral mRNAs [158]. While the reported results suggested similar
effects in E. helvum, Epo. buettikoferi and R. aegyptiacus cells, control of ONNV
replication seemed to be more efficient in the applied bat cells. The similarity of
the reduction levels of secreted IFN could be explained by a more pronounced and
efficient upregulation of ISGs in bat cells. To investigate this, the mRNA abundance
of two different ISGs (MxA and ISG56) as well as two reference genes ( beta actin
and TBP) were analysed (Figure 3.12a and 3.12b) and compared to the amounts of
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secreted IFN 0 and 24 hpi (Figure 3.12c and 3.12d).
(a) (b)
(c) (d)
Figure 3.12: IFN protein secretion and ISG expression.
(a) Expression of MxA after 0, 8 and 24 hpi with ONNV in EidNi/41.3,EpoNi/22.1, MEF
and MA104 cell lines measured by species-specific RT-PCR assay. (b) Expression ISG56
mRNA levels after ONNV infection measured by species-species RT-PCR. Both (a) and (b)
show increasing levels of MxA and ISG56 mRNA expression over time. (c) Comparison of
mRNA fold-induction of IFN stimulated genes (MxA and ISG56) to secreted IFN protein
at time points 0 hpi and 24 hpi. Expression was not affected by IFN protein downregulation
indicating that there was no general transcriptional shutoff. (d) Test of different cell clones
and cell cultures 24 hpi showing that MxA mRNA was upregulated in bat cell cultures
upon ONNV infection.
The absolute values of MxA and ISG56 mRNA increase over time are shown
in Figure 3.12 a and b. In EidNi/41.3 cells the level of MxA mRNA induction
in relation to IFN in the supernatant was more than 1,000-fold higher compared
to the same ratio for ISG56. Only for EpoNi/22.1 highest amount of MxA and
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ISG56 mRNA levels were detected at 8 hpi followed by a reduction of mRNA levels
after 24 hpi. In contrast to IFN secretion the ratios showed an approximate 10-fold
increase at 24 hpi indicating no general block of transcription after ONNV infection
(Figure 3.12c). The clonal and mixed cultures EidNi/41.2 and EidNi/4 as well as
RoNi/7 showed a 100-fold higher induction of MxA mRNA in comparison to ISG56,
which indicated a related reaction pattern (Figure 3.12d). The results suggested
a highly efficient IFN signalling-dependent induction of ISG mRNA in E. helvum,
Epo. buettikoferi and R. aegyptiacus bat cells, which could explain a better control
of ONNV replication in both applied bat cell lines.
3.4.4 ONNV infection ablates the expression of IFN
stimulated genes
ONNV infection did not affect mRNA transcription. Since it was observed that
alphaviruses can lead to translational shutoffs [65], protein expression was analysed
by Western blot analysis (Figure 3.13). The protein expression of MxA, ISG56 (p56)
and actin were compared to uninfected, RVFV 13 and ONNV infected cells. After
RVFV 13 infection MxA expression was clearly higher or similar to the uninfected
control cells, whereas for p56 protein the expression level maintained (Figure3.13).
In contrast, ONNV infection resulted in decreased expression levels of MxA and
p56 proteins. This effect was generally more pronounced for MxA than for p56.
The data pointed to a virus-related effect on the IFN-dependent signalling via
the JAK/STAT-pathway rather than a JAK/STAT-independent induction of ISGs.
MEF cells formed an exception with no reduction in MxA expression (Figure 3.13).
The bat cell lines EidNi/41.3, EpoNi/22.1 and RoNi/7 showed clear induction of
MxA mRNA, but the production of the antiviral protein was antagonized by ONNV
to a larger extent than in cells from rodents or primates.
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Figure 3.13: ONNV infection ablates the expression of IFN stimulated genes.
(a) Cells were either left untreated (-) or infected with RVFV 13 (+) or ONNV (OV).
After 24 h proteins were extracted from cells. Same amount of proteins were subjected to
SDS-PAGE followed by a Western blot analysis. Mouse-anti-MxA, mouse-anti-ISG56 and
mouse-anti-actin IgG antibodies were applied at dilutions 1:1000 followed by a peroxidase
labelled goat-anti-mouse secondary antibody (1:20000). In all cell lines infection with
ONNV did not induce the expression of MxA and p56 and was less or similar to untreated
cells. (b) To exclude cell clone specific effects additional EidNi and RoNi bat cell cultures
were included (EidNi/41.2; EidNi/41 and RoNi/7) as well as a human A549 cell line.
3.4.5 Efficient ONNV replication upon infection at low MOI
The effects on IFN and ISG protein reduction were found as results of ONNV rep-
lication. Alphaviruses, however, are prone to mutations in the 5`UTR [103, 210],
nsP3[13], or nsP2[53] genes which result in low replication levels enabling the virus´
persistence without IFN-dependent elimination. However, the observed increase of
IFN mRNA expression upon ONNV infection (Figure 3.11a and 3.11b) and the high
virus titers of up to 105 PFU per mL (Figure 3.10b) indicated that replication was
not limited. To further exclude this, virus replication was studies upon infection
with an MOI of 0.0025 in selected cell lines. At time point 0, 8 and 24 hpi virus
replication was analysed by real-time RT-PCR (Figure 3.14a). Viral supernatants
taken 24 hpi were titrated to determine the concentration of infectious particles
(Figure 3.14b) and enable the definition of the specific infectivity of the virus (Fig-
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ure 3.14c). Although the experiments were performed with 1,000-fold lower MOI,
the virus growth was efficient in all cell cultures. The specific infectivity showed the
same strong infectious particle formation. With this efficient particle formation in
all cell lines tested it was concluded that the decrease in IFN and ISG protein levels
was not a result of attenuated viral replication.
(a) (b)
(c)
Figure 3.14: Efficient ONNV replication upon infection at low MOI.
(a) In order to access if insufficient viral replication led to a delayed or ablated IFN pro-
duction in cells a growth kinetic at low MOI was performed (MOI 0.0025). Cells were
inoculated with ONNV and supernatants analysed at 0, 8 and 24 hpi by real-time RT-
PCR. Virus replication could be detected in all cell lines. (b) Supernatants were titrated
after 24 hpi confirming the PCR results. (c) PFU to ONNV PCR unit (U) ratio after
infection of cells with ONNV at an MOI of 0.0025.
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3.5 Comparison with other Old World alphaviruses
(SINV and CHIKV)
Bat cells as well as reference cell lines could be efficiently infected by ONNV. Des-
pite elevated mRNA levels for IFN and ISGs the amount of corresponding proteins
decreased suggesting an ONNV-related translational shutoff. In order to investigate
whether this is a common feature upon alphavirus infection two other alphaviruses,
SINV and CHIKV, were analysed for activation of the IFN response. The experi-
ments were limited to one bat cell line (EidNi/41.3) and one rodent reference cell
line (MEF).
3.5.1 CPE detection after SINV or CHIKV infection
SINV is one of the first described and therefore extensively characterized alphavir-
uses. CHIKV re-emerged in 2005 and 2006 illustrated the potential threat to public
health and the necessity to understand mechanisms involved in alphavirus biology
[112]. Earlier findings showed high replication rates for both viruses in cell culture
systems [189]. In order to analyse the replication behaviour of SINV and CHIKV in
EidNi/41.3 compared to MEF cells, the cell lines were infected with MOI 2.5 to en-
sure synchronised infection. Morphological signs of cell death were determined at 0,
4, 8, 10 and 24 hpi. After SINV infection first morphological signs of cell death were
observed in EidNi/41.3 cells already 4 hpi. CPE were continuously stronger than in
MEF cells over time. The cell monolayer was completely destroyed for EidNi/41.3
cells 24 hpi, while in MEF cells only first signs of CPE were detected (Figure 3.15a).
Figure 3.15b shows the CPEs after CHIKV infection. In both cell lines morpho-
logical changes were first detected at 8 hpi with similar patterns of morphological
change over time. A complete destruction of the cell monolayer in EidNi/41.3 cells
was visible by 24 hpi (Figure 3.15b).
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(a) (b)
Figure 3.15: CPE detection after SINV or CHIKV infection.
Various cells were infected with 3 different MOIs 2.5, 0.1 and 0.0025. The cells were
observed and CPE appearance was validated (1= small changes to 3= all cells dead). A
strong cytopathic effect was observed after SINV as well as CHIKV infection.
3.5.2 SINV and CHIKV replication in bat or MEF cells
The observed CPEs upon SINV and CHIKV infection revealed that an incubation
time of 24 hpi was too long to generate reliable samples. To analyse virus replica-
tion and growth, induction of the IFN response and effects on the ISG expression
sampling was reduced to 4 and 10 hpi with an MOI of 2.5 for both viruses. Viral
replication was analysed with virus-specific RT-PCR assays. Figure 3.16a shows a
100-fold increase of genome equivalents between 4 and 10 hpi for both viruses. SINV
already showed high amounts of GE after 4 hpi, indicating a more rapid replication
in comparison to CHIKV infection, which showed RNA levels of at least 100-fold
lower. But at 10 hpi an 10,000-fold increase in GE was detected in MEF cells after
CHIKV infection and with this the replication rate was almost similar to SINV in-
fection. Interestingly, in EidNi/41.3 cells CHIKV RNA levels were lowest. Since
measured RNA levels only describe the replication but not the effective formation
of viral particles, the supernatants taken 10 hpi were then titrated to determine
the infectious particle formation. In both cell lines SINV was able to produce viral
particles to very high titers (Figure 3.16b). In correlations with the difference in rep-
lication levels between SINV and CHIKV, SINV infection resulted in higher titers.
The ratio between PFU and PCR U per mL expressing the specific infectivity was
equal for SINV and CHIKV in both cell lines.
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(a) (b)
(c)
Figure 3.16: SINV and CHIKV replication in bat or MEF cells.
(a) For synchronized infection cells were inoculated with SINV at an MOI 2.5 and su-
pernatants were harvested at 4 and 10 hpi. After viral RNA isolation (triplicates) the
concentration was measured by SINV specific real-time RT-PCR assay. SINV and CHIKV
PCR units (U) per mL were determined. The dilution end-point was defined as one PCR
unit. Virus replication could be detected in both cell lines. The increase of genome equival-
ents per mL were approximately 100 to 1,000-fold at 10 hpi. (b) Titration of supernatants
showed an increase of PFU per mL (titer of inoculum was subtracted) after 10 hpi of 1,000
to 10,000-fold. (c) The ratio of log-10 increase PFU/mL to SINV or CHIKV PCR units
were similar in both cell lines indicating an efficient particle formation.
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3.5.3 IFN induction after infection with SINV and CHIKV
After verifying viral growth, the IFN induction upon SINV or CHIKV infection
was determined. IFN mRNA levels were measured by cell-specific IFN real-time
RT-PCR assays and compared to the levels of TBP levels. In EidNi/41.3 cells the
observed IFN induction after SINV infection increased over time, while the IFN
induction after CHIKV infection was already induced to the same extent as after
4 hpi. This indicated a fast IFN response of the cells to virus infection (Figure 3.17a).
In MEF cells IFN induction was similar to the SINV infection in EidNi/41.3 cells
with highest IFN mRNA transcription levels at 10 hpi (Figure 3.17a). However the
increase in IFN mRNA transcription was approximately 10,000-fold after CHIKV
infection and only 1,000-fold after SINV infection.
In Figure 3.17b the comparison of secreted IFN to the levels of induced IFN mRNA
is shown. The values for cells treated with RVFV 13 or poly IC indicated protein
synthesis (Figure 3.17b ). After SINV and CHIKV infection both cell lines clearly
showed reduction of secreted IFN protein. For EidNi/41.3 cells a strong effect on
mRNA levels was also observed (Figure 3.17b). This effect was less intense in MEF
cells, which was similar to mRNA levels after infection with ONNV (Figure 3.11d).
In conclusion, the IFN protein reduction was SINV- and CHIKV-specific.
(a) (b)
Figure 3.17: IFN induction after SINV and CHIKV infection.
(a) Mean fold change in IFN-β gene expression in EidNi/41.3 and MEF cells after 4 and
10 hpi with SINV and CHIKV. Both viruses lead to an increase of IFN-β after 10 hpi.
Interestingly in EidNi/41.3 cells saturating expression amounts of IFN-β mRNA level are
already reached after 4 hpi with CHIKV.(b) Comparison of secreted IFN protein to IFN-β
mRNA 10 hpi with SINV and CHIKV, RVFV 13 infection and poly IC transfection. SINV
and CHIKV replication could be related to IFN protein reduction.
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3.5.4 ISG induction after SINV and CHIKV infection
Since ONNV did not induce a general transcriptional block proven by an increase in
MxA mRNA levels ( Figure 3.12), it was tested if this was also true after SINV and
CHIKV could be confirmed. Therefore MxA and ISG56 expression levels were meas-
ured with specific real-time RT-PCR assays and compared to secreted IFN levels.
The direct comparison demonstrated that in EidNi/41.3 cells the transcription of
MxA was almost 100-fold higher compared to the same ratio for ISG56 (Figure
3.18a).
(a) (b)
Figure 3.18: ISG induction after SINV infection.
(a) Comparison of mRNA fold-induction of IFN stimulated genes (MxA and ISG56) to
secreted IFN protein at time points 4 and 10 hpi. Expression of MxA was stronger affected
by IFN protein down regulation in both cell lines after infection with SINV. The effects on
ISG56 expression were similar in both cell lines after SINV and CHIKV infection. (b) Cells
were either left untreated (-) or infected with RVFV 13 (+), ONNV (OV), CHIKV (CV) or
SINV (SV). After 10 h proteins were extracted from cells infected with SINV and CHIKV
and at 24 hpi from cells infected with ONNV and RVFV and untreated. Equal amount of
proteins were subjected to SDS-PAGE followed by a Western blot analysis. Mouse-anti-
MxA, mouse-anti-ISG56 and mouse-anti-actin IgG antibodies were applied at dilutions
1:1000 followed by a peroxidase labelled goat-anti-mouse secondary antibody (1:20000). In
all cell lines infection with ONNV did not induce the expression of MxA and p56 and was
less or similar to untreated cells. After the infection with CHIKV or SINV MxA protein
was only in reduced amounts detectable, while p56 abundance was similar to untreated
cells.
In MEF cells the difference between MxA and ISG56 was only depicted after
CHIKV infection. The results were similar to the ones after ONNV infection and
confirmed that there was no general block of transcription and a highly efficient IFN
signalling-dependent induction of the ISGs in the bat cell line EidNi/41.3.
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To analyse if a translational shut off could explain reduced protein levels West-
ern blot analysis was performed. It was shown that ONNV infection resulted in
decreased expression levels of MxA and p56 (Figure 3.18b). This effect was also
observed after SINV and CHIKV infection. In general the effect was more pro-
nounced for MxA than for p56. Interestingly, in MEF cells the reduction of MxA
protein expression after ONNV infection was not detected, but was clearly visible
upon infection with SINV and CHIKV (Figure 3.18b). Overall the production of
this antiviral protein was antagonized in EidNi/41.3 cells to a greater extent than
in MEF cells.
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4.1 Bat cell culture characterization
With only two bat cell lines commercially available [68, 67], this study presents
three new cell culture systems comprising different bat species. One major concern
when using cell cultures from wild animals like bats are pathogenic contaminants.
The severe impacts of contaminated cell cultures were shown in 1967 when wild
captured monkeys were brought to Europe to generate cell cultures in diverse labor-
atories for vaccine research [181]. In Marburg, Frankfurt and Belgrade laboratory
workers with direct contact with blood, organs, and cell cultures from Cercopithecus
aethiops showed severe and fatal haemorrhagic fever [182, 172]. The cause of the
disease was identified as the Marburg virus, which is a genus of the family Filovi-
ridae [181]. Since the bat cell lines were gained from captured wild bats, they were
tested for lyssaviruses, filoviruses, mycoplasma and SV5 by RT-PCR and found to
be negative for all. As contaminations might be introduced during passaging, my-
coplasma and SV5 contaminations were frequently tested. In particular SV5 is an
overlooked problem. The V protein of the virus targets STAT-1 and inducing its
degradation, which blocks the IFN-signalling pathway [38, 82, 203]. In addition, the
protein blocks the MDA5-mediated activation of the IFN-promoter and therefore
inhibits IFN-induction [28, 27, 148]. Mycoplasmic contaminations have severe in-
fluences on several cell culture properties by leading to changes in cell metabolism,
performance and viral activity [156, 117, 40]. The adverse effects on IFN production
and activity show the great impact of mycoplasmas in virus-host interaction assays
[40]. As the investigation of the IFN response was a major part of this study, these
contaminations had to be ruled out.
All cells in the presented study were immortalised by lentiviral transduction of the
large T antigen of SV40 [5]. The expression of the SV40 Large T-antigen inhibits
the pRB- and p53-dependent responses in cellular pathways [5]. This effect results
in the cells escaping apoptosis and permanent re-entering of the S-phase of the cell
cycle [5]. The random integration of the large T-antigen can affect important genes
and can lead to dysfunctions in cellular signalling cascades.
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As the focus in this study was the IFN response upon virus infection, the integrity
of IFN response signalling pathways had to be ensured. Cell lines EidNi/41.3 and
EpoNi/22.1 were tested for their reactivity to IFN stimuli like poly IC and RVFV 13.
The cells showed the same or higher sensitivity to commonly used stimulators of IFN
gene expression compared to MEF and MA104 cell lines indicating that the IFN in-
duction pathway within the cells was not affected by immortalisation. In addition,
subclones and mixed cultures were included in some experiments to confirm the res-
ults and exclude subclone-specificity. The newly generated EidNi and EpoNi as well
as additional RoNi bat cell lines are well-characterized and highly IFN competent
by showing high IFN mRNA induction, efficient IFN protein secretion and highly
efficient ISG induction.
4.2 Cell line specific VSV-bioassays to allow
comparison of effective IFN response between
different cell lines
For investigations into the IFN response, particularly the comparison of secreted
IFN is challenging, since the commonly used methods are limited to certain species
or different IFN specificities [125]. IFN bioassays which rely on the induction of an
antiviral state by upregulated ISG, are restricted by the compatibility between the
IFN of interest and the IFN receptors of the used cells [204, 25]. Also commercially
available ELISA assays show similar restrictions to particular types of IFN or host
species.
In this study a species-specific VSV-bioassay based on the determination of IFN
concentration with the help of pan-species IFN, enabled the direct comparison of
bioactive secreted IFN after challenging with the same pathogen. Each cell line
has a defined EC50 value, which facilitates the exact determination of total IFN
concentrations and enables direct comparison between species. The sensitivity to
the pan-species IFN is not related to the origin of the cells and VSV enables a fast
adaptation of the newly developed VSV-bioassay to cell lines of interest. Other
methods for IFN detection such as ELISAs [115] or MxR-systems [120] are either
limited in the IFN type and the host species or restricted to a specific host organism,
which detects only species-specific IFN. These limitations to IFN types or cell lines
can be prevented with the established assay, since the secreted IFN is recognized by
the cell-specific IFN receptors. Additionally, the EC50 factor values, determined by
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the help of a pan-specific IFN, enabled the correlation and direct comparison of the
measured IFN values by excluding host-specific variations.
To enable the comparison of the IFN response to virus infections between bat,
rodent and human cell lines promoted the development of an assay which is species-
independent. In parallel with the group of F. Weber in Freiburg, the advantage of
pan-species IFN was used to develop a bioassay with the ability to measure secreted
IFN independently of the cell line origin [105]. Using a Renilla luciferase-expressing
RVFV (RVFV-Ren) the group developed a bioassay with short incubation times and
a high sensitivity up to 1 U/mL IFN [105]. They could show that the RVFV-Ren is
species-independent which allows interspecies comparison [105]. Unfortunately, the
RVFV-Ren is patented (personal communication with F. Weber), which limits its
availability [105]. Furthermore, the read-out depends on the Renilla luciferase assay
system provided by Promega®, which is expensive [105].
The modification of the VSV-bioassay with pan-species IFN optimized the assay as
a tool to be able to measure species-independent secreted IFN concentrations. The
establishment of the VSV-bioassay for additional cell lines of interest, like newly
identified reservoirs of human pathogenic viruses or possible zoonotic viruses iden-
tified in, for example bats, is fast and uncomplicated. The advantages of using a
modified version of the well established VSV-bioassay makes the assay available to
any BSL 2 laboratory. The read-out is based on plaque formation and counting,
which is independent of any company or measuring system and is therefore more
cost-effective. With the EC50 value interspecies comparison of secreted IFN after
challenging the same virus is possible and allows to draw conclusions about the
specific IFN response.
Furthermore IFN response antagonists of viruses of interest can be studied, since
increasing mRNA levels are not necessarily in accordance with bioactive secreted
IFN [225].
4.3 Serology
Bats have been shown to carry a large diversity of highly pathogenic agents [78]. It
is therefore important to obtain an estimate on the distribution of pathogens within
bat colonies in particular in those that are living in proximity to humans. In this
study a serological approach was chosen to get a broader view on the prevalence of
alphaviruses in bats. The serological study included 16 different bat species. In total
5% of the bat serum samples showed cross-reactivities to either VEEV or CHIKV
80
4 Discussion
antigens. Despite the fact that most studies are based on nucleic acid detection
methods [42], we chose a serological approach. The main reason for this choice
was that nucleic acid based methods have a major disadvantage by depending on
the right sampling time point and on certain virus concentrations in the analysed
specimens[45]. Viraemic phases can be very short and many pathogens might be
overlooked due to low viral loads. Here the serological survey shows an advantage
by detecting virus-specific antibodies, which can, in many cases, be detected a life
time.
Compared to paramyxoviruses and CoV cross-reactivity to alphaviruses was low
[42, 201]. For paramyxoviruses a prevalence of 40% (approximately 10,000 individu-
als) was determined, showing that the virus diversity in bats is larger than expected
[43, 44, 219] and tempting bats to be the animal reservoir for mammalian paramyx-
oviruses [42]. For CoV a cross-reactivity of 10% was detected in bat serum samples
from Africa [134], following investigations revealed that bats in Africa carry SARS-
related agents [145]. Since SARS-CoV originated from the Chinese horseshoe bats,
the findings of CoV prevalence in Africa underlined the reservoir function of the
animals for this virus family [108]. These two examples show that the prevalence
of a virus in the reservoir animal is high, which indicates that bats are most likely
accidental hosts for alphaviruses but might play a role in the natural transmission
cycle.
As early as 1973 Seymour et al. proposed that neotropical bats could serve as
alternate hosts in the enzootic cycle maintaining VEEV transmission [168]. But the
role of bats in the transmission cycle and ecology of this virus has not yet been de-
scribed [168]. The bat species A. jamaicensis showed the highest prevalence among
the neotropical bats with an average of 5% which complements the results of Ubico
et al. from 1995 [202]. Interestingly, VEEV and CHIKV, which are defined to
be distributed on separate continents [99], showed identical prevalences in almost
all tested bat species. Reactivity of Old World bats with a New World alphavirus
antigen could be explained by a cross-reactivity of sera with both antigens as ob-
served for other alphaviruses by Vollmar et al. [211]. But since several sera reacted
only with one antigen this can be ruled out as a general explanation. In fact, one
reason could be that the actual diversity of alphaviruses might be much higher in
bats as e.g. observed for paramyxoviruses and CoV. With an abundance of 20% for
both viruses in the bat M. torquata, this bat species showed the highest prevalence
within the Old World bat species. In comparison the species R. aegyptiacus showed
an abundance of 1% for VEEV and 2% for CHIKV. Both species belong to the fru-
givorous bats but are differently distributed and have different roosting behaviours
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[133, 14].
The geographical distribution and various habitats of bats could be a reason for
the observed differences in alphavirus abundance between the different bat species.
Phylogenetic analyses of Ebola virus identified in bats corresponded to the human
epidemic strain (Zaire Ebola virus) and allowed the conclusion that the virus out-
breaks can be linked to the geographic distribution and roosting behaviour of the
reservoir bat species [151]. Since alphaviruses are transmitted by several mosquito
genera like Aedes or Culex and others [99], the distribution of these viruses is prob-
ably primarily linked to the prevalence of these vectors. Mosquito prevalence has
shown to be sensitive to ecological changes which influences the viral variety for
the different regions [91]. With M. torquata being highly adaptive to new envir-
onments and merging to plantation regions [133], it is suggested that this species
has a higher exposure to mosquitoes serving as alphavirus vectors instead of R.
aegyptiacus roosting in caves [14].
It is tempting to speculate that the prevalences of alphavirus cross-reactivities in
both bat species can probably be linked to the different habitats and roosting beha-
viours of the animals. The present study shows the relevance of serological studies
to support nucleic acid detection assays or virus isolation by directing the focus of
the research to positive samples. Since the relevance of bats in virus ecology has
become a new focus in virology, working together with bat ecologists could complete
interpretations and analyses of serological studies. This may also assist in explaining
the causal connection between virus prevalence and geographical distribution of the
animals.
4.4 Comparable mechanisms of IFN response
between bat, murine and human model cell
lines
The high diversity and quantity of pathogens detected in bats [24] indicates that
these flying mammals and the missing overt clinical symptoms upon infection may
have developed strategies to minimize viral pathogenesis. The IFN response, which is
known to be the first barrier within the mammalian cells, could be one possibility for
bats to escape the infection. Only a few aspects of bat IFN response are known, such
as identified homologous genes of human IFN response pathway [55, 124, 164, 26].
In this study the IFN response of newly introduced immortalized bat cell lines was
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compared to a murine cell line, MEF, and a human cell line, MA104. The cell lines
showed the same IFN response to ONNV, SINV and CHIKV infections which was
detected with species-specific methods on mRNA-detection and on bioactive protein
analysis. After virus-induced IFN induction, the IFN protein synthesis was blocked.
Partially synthesized IFN was able to induce MxA and ISG56 mRNA expression
but the translational block diminished measurable protein levels. Although the
ratios might differ to some extent between the various viruses, taken together the
data suggest a translational rather than a transcriptional shutoff. Similar effects
were shown for CHIKV in human fibroblasts by White et al. [215]. It could be
proven that the innate immune activation was dependent on the adaptor molecule
IFN promoter stimulator 1 (IPS-1) and that CHIKV induced a translational shutoff
[215]. In this study newly generated bat cell lines were shown to be sensitive to
IFN-induction and able to secrete bioactive IFN. IFN-signalling was demonstrated
with species-specific RT-PCRs for the ISGs MxA and ISG56, which indicated similar
mechanisms to well-characterized mammals.
Current research focuses largely on the various mechanisms employed by the host
to control an invading virus. The fact that mammals like bats serve as reservoirs for
viruses, indicates that virus-host interaction on the type I IFN response level might
be crucial for the course of infection.
Therefore the IFN response of bats was analysed in detail upon virus infection
in this study. The different IFN inducers like poly IC, attenuated virus RVFV 13
or wild type viruses like ONNV, SINV and CHIKV were considered for every cell
culture background. While in EidNi/41.3, MEF and MA104 cell lines the sensitivity
to poly IC and RVFV 13 were of similar extent, the EpoNi/22.1 cell line showed a
higher sensitivity to RVFV 13 (Figure 3.7a). Not only the total amount of IFN was
measured, but also the ratios of secreted IFN and mRNA levels. Both commonly
used IFN inducers showed high relative levels of secreted IFN that were comparable
for all cells (Figure 3.7b). However, in cells infected with ONNV, SINV or CHIKV,
the levels of relative secreted IFN-β were clearly reduced. This can be explained by
a induction of PKR-independent translational shutoff [215].
The IFN response in bat cells was similar or more sensitive compared to the IFN
response in reference cell lines. The higher sensitivity to IFN in the signalling cas-
cade suggests that smaller amounts of IFN might be enough to induce the antiviral
state in bat cells. Earlier findings confess the IFN-β mRNA expression upon poly IC
transfection for P. alecto and other bat species [225, 187], additionally IFN-λ ex-
pression was predicted to play a major role in bat IFN response [225]. After virus
infection the type I IFN expression was suggested to be immediately blocked by
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virus antagonists [224]. The type III IFN expression could compensate for the loss
of the IFN-mediated antiviral activity, thereby making the antiviral strategy of bats
less susceptible to suppression by viral immune evasion mechanisms. However, bio-
active IFN was not analysed in those studies [224]. As shown in the present study
the differences between type I IFN mRNA and effectively secreted IFN-β can vary
to a very high degree. To draw conclusions about the IFN response of cell lines it is
necessary to measure bioactive IFN. Interestingly, an IFN-independent virus control
has been predicted by Virtue et al. [208] indicating great possibilities for alternative
virus control. White et al. results underlined alternative virus control by showing a
PKR-independent block of cellular protein synthesis.
The present study emphasises that the release of bioactive IFN must be considered
in the interpretation of results to assess whether the cells are able to counteract the
virus infection. All steps of the antiviral response have to be analysed to draw
conclusions on which level viruses might intervene with the host IFN response. The
results are important indications to understand the bat IFN response and but need
to be further analysed in future studies, with focus on for example other ISGs or
IFN antagonists.
Conclusion
Taken together the newly generated bat cell lines were IFN sensitive and therefore
ideal tools for in-depth studies on the IFN response system upon viral infections.
The optimized VSV-bioassay enabled together with the species-specific qRT-PCRs
an detailed analysis of IFN -induction, -signalling and -secretion with considerations
of viral antagonism strategies. With the help of a serological survey on alphavirus
prevalence in bats it could be shown that bats are most likely not the reservoir of
alphaviruses but may serve as hosts in the enzootic cycle. The induction of sero
conversion and thus the ability to infect bats led to further investigations upon IFN
response after alphavirus infection. Here it was shown that bat cell lines react in the
same or even more sensitive way as the reference cell lines indicating a strong IFN
mRNA expression, followed by inhibited protein secretion postulating a translational
rather than a transcriptional shutoff.
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Bats have been identified as reservoir for human pathogenic zoonotic viruses like
Rabies, Marburg or Henipaviruses. The fact that bats carry viruses without showing
clinical symptoms, raised the question if these flying mammals have evolved specific
mechanisms to suppress virus replication. To address this question a bat cell culture
model was established to investigate the IFN response upon virus infection.
First, cell lines of E. helvum, Epo. buettikoferi and R. aegyptiacus were generated,
immortalised and characterized. IFN sensitivity upon viral and artificial IFN-stimuli
was analysed by pan-bat IFN real-time RT-PCR assay. To enable comparative
analysis of species-specificity and inter-species bioactive IFN secretion the VSV-
bioassay was optimized. It was adapted to each cell line and the pan-species IFN
enabled with the EC50 factor the determination of relative secreted bioactive IFN
concentration.
To determine IFN-signalling, the mRNA expression levels of several IFN stimu-
lated genes (ISGs) were determined with established species-specific real-time RT-
PCR assays. These methods enabled comparable studies between bat, murine and
human cell lines. The role of bats within the life cycle of arthropod borne alphavir-
uses is not clear. The prevalence of cross-reactive antibodies was determined by an
Immunofluoresence assay, analysing bat sera from several continents and species. In
average 5% of the serological samples were found positive which is a comparably low
seroprevalence. Interestingly, some Old World bat samples showed exclusive reactiv-
ity with New World alphaviruses and vice versa. This cross-reactivity might indicate
that the phylogenetic range of alphaviruses in bats could be much higher. In an al-
phavirus infection model with O´nyong-nyong virus (ONNV) high IFN-induction on
mRNA level was detected in all cell lines. Conversely, IFN secretion was reduced.
Although IFN-signalling seemed to be more sensitive on mRNA expression level in
bat cell lines, this could not be confirmed on protein levels. These results indicated
a translational rather than a transcriptional shutoff upon alphavirus infection in
bat cell lines. To investigate if these results were ONNV-specific, two additional al-
phaviruses, Sindbis and Chikungunya virus (SINV and CHIKV), were tested. These
infection experiments showed similar results suggesting a general mechanism of al-
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phaviruses to antagonize the IFN response. Interestingly, bat cell lines showed
similar IFN response as human cell lines. Generated bat cell lines, designed pan-bat
or species-specific real-time RT-PCR assays and the optimized VSV-bioassay alto-
gether enable a detailed analysis of the IFN response to virus infections in bat cell
lines, which was especially on the bioactive IFN protein level in this comparable way
not possible before.
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Zusammenfassung
Fledermäuse wurden als Wirte von zoonotischen, humanpathogenen Viren, wie Toll-
wut, Marburg- oder Henipaviren, identifiziert. Als Träger von pathogenen Viren
zeigen die Fledermäuse keine klinischen Symptome einer Erkrankung. Daher wurde
spekuliert, ob sie im Laufe der Evolution spezielle Mechanismen zur Unterdrück-
ung der Virusreplikation entwickelt haben. Zur Verifizierung dieser Frage, wurde
die IFN-Antwort, bestehend aus IFN-Induktion, -Sezernierung und -Signalwirkung,
auf Virusinfektionen in Fledermauszellen im Vergleich zu murinen und humanen
Zellkulturmodellen untersucht.
Zunächst wurden Zellkulturen von E. helvum, Epo. buettikoferi und R. aegyp-
tiacus generiert, immortalisiert und charakterisiert. Mit Hilfe eines pan-spezies
IFN Real-Time RT-PCR Assays konnte gezeigt werden, dass die generierten Fle-
dermauszelllinien in der Lage sind, sowohl auf virale als auch auf artifizielle IFN-
Stimuli zu reagieren. Die Optimierung des VSV-Bioassays ermöglicht die Detektion
von sezerniertem IFN unter Berücksichtigung der Spezienspezifität und Interspezi-
fität. Dazu wurde das Assay individuell an jede Zelllinie angepasst und mit Hilfe
des EC50-Faktors die Vergleichbarkeit der Konzentration des sezernierten IFNs er-
möglicht.
Zur Bestimmung der IFN-Signalwirkung wurden verschiedene ISG mRNA- Ex-
pressionen mittels Spezies-spezifischen Real-Time RT-PCR Assays bestimmt. Durch
die Entwicklung der entsprechenden Assays war es möglich, vergleichende Experi-
mente durchzuführen. Ob Fledermäuse ebenfalls als Wirte für Alphaviren in Frage
kommen, wurde bisher nur vermutet. Mit Hilfe einer serologischen Studie wurde
daher die Prävalenz von kreuzreagierenden Antikörpern gegen Alphaviren in Fle-
dermäusen verschiedenster Kontinente bestimmt. Es wurde eine Prävalenz von
durchschnittlich 5% festgestellt. Dies ist eine vergleichsweise niedrige Seroprävalenz.
Einige Altweltfledermausproben waren interessanterweise nur für Neuweltalphaviren
positiv und umgekehrt. Dies lässt vermuten, dass die phylogenetische Spanne in-
nerhalb der Alphaviren in Fledermäusen größer ist, als bis jetzt angenommen.
In einem Alphavirusinfektionsmodell konnte gezeigt werden, dass die Infektion mit
ONNV in allen Zellen eine hohe IFN-Induktion zur Folge hatte. Kontrovers hierzu
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konnte eine Reduktion der IFN-Sezernierung gemessen werden. Obwohl die IFN-
Signalwirkung bei Fledermäusen auf mRNA-Ebene sensibler zu sein schien, konnte
dies auf Proteinebene nicht bestätigt werden. Daher kann auch bei Fledermäusen
auf einen Translationsabbruch nach Alphavirusinfektion geschlossen werden. Zur
Klärung, ob die Ergebnisse ONNV-spezifisch waren, wurden die gleichen Versuche
noch mit zwei weiteren Alphaviren (SINV und CHIKV) durchgeführt. Die Ergeb-
nisse hieraus bestätigen, dass Fledermauszellen eine der humanen ähnliche IFN-
Antwort besitzen und die beobachteten Mechanismen wahrscheinlich allgemeingültig
für Alphaviren sind.
Künftig kann also die IFN-Antwort auf Virusinfektionen zwischen Fledermaus-
und humanen Zelllinien vergleichend auf allen Ebenen untersucht werden. Die gen-
erierten Zelllinien, die entwickelten Spezies-spezifischen Real-Time RT-PCR Assays
und das optimierte VSV-Bioassay ermöglichen im Zusammenspiel detaillierte Erken-
ntnisse über die IFN-Antwort der Fledermauszellen auf Virusinfektionen, die im
Besonderen auf der bioaktiven Proteinebene noch nahezu unerforscht ist.
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Abbreviation Meaning
A a Anti
A Adenine
APS Ammoniumperoxodisulfat
aa Amino acid
A549 Adenocarcinomic human alveolar basal epithelial
cells
B b-ME b-Mercaptoethanol
b Bat
bp Base pair
BSA Bovines Serum Albumin
BSL Biosafety level
C C Cytosin
cDNA copy DNA
CHIKV Chikungunya virus
CO2 Kohlendioxid
CoV Coronavirus
Cy Cyanine
D D Aspartic acid
DLA Dual Luciferase Assay
DMEM Dulbecco's Modified Eagles Medium
DNA Desoxyribonucleic acid
dNTP Desoxyribonukleosid-Triphosphat
dsRNA Double stranded RNA
DTT Dithiothreitol
E EC50 Half maximal effective concentration
EDTA Ethylenediaminetetraacetic acid
EGFP Enhanced Green Fluorescent Protein
E. helvum Eidolon helvum
Epo. Epomops
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6 Abbreviation
ER Endoplasmatic Reticulum
EtBr Ethidiumbromid
EtOH Ethanol
F For forward primer
FF Firefly-Luciferase
FITC fluorescein isothiocyanate
F.W. Friedemann Weber
G G Guanine
g gravitational force
GE Genome equivalents
H h hour
hpi hours post infection
hu human
H2O Water
HA Haemaglutinine
HCl Hydrochloric acid
HEP2 Human epidermoid carcinoma cells
hpi hours post infection
HRP horseradish peroxidase
I IF Immuno fluorescence
IFN Interferon
IFN-b Interferon-b
IGEPAL CA-
630
octylphenoxypolyethoxyethanol
IOV Instiute of Virology
IP Immunoprecipitation
ISG IFN stimulated gene
ISGF Interferon stimulated gene factor
ISRE Interferon-stimulated response element
K Kb Kilo base pairs
kDa Kilo Dalton
L LBV Lagos bat virus
lp low passage
M M Mouse
MA104 African green monkey fibroblast cells
MDA5 Melanoma differentiation factor-5
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MEF Mouse embryonic fibroblast cells
MeOH Methanol
MOI Multiplicity of infection
mRNA messenger RNA
MxA Myxovirus-resistance A
N Ni Kidney
Nsp non-structural protein
O OAS 2´,5´-Oligoadenylate synthetase
ORF Open reading frame
ONNV O`nyong-nyong virus
P PAGE Polyacrylamid Gelelektrophoresis
PBS Newline Phosphate buffered saline
PCR Polymerase chain reaction
PFU Plaque forming units
pH pondus hydrogenii
PI III Proteinase Inhibitor III
b-PL b-Propiolactone
Poly IC Polyinosin:Polycytidyl acid
Prb Probe
PVDF Polyvinylidenfluorid
R Rev Reverse Primer
RIPA Radio immuno precipitation assay
RIG-I Retinoic acid inducible gene-I
RL Renilla-Luciferase
RLU Relative light units
RNA Ribonucleic acid
RPM Rotation per minute
Ro Rousettus
RT Room temperature
RT-PCR Reverse transcriptase PCR
RVFV Rift Valley Fever Virus
S SARS Severe Acute Respiratory Syndrome
SDS Sodium dodecylsulfate
sgRNA subgenomic RNA
SINV Sindbis virus
SS III SuperScript III Reverse Transkriptase
ssRNA Single strand RNA
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6 Abbreviation
STAT signal transducer and activator of transcription
SV40 Simian Virus 40
T T Thymin
TEMED N,N,N`,N`-Tetramethyl-ethylendiamin
TAE Tris-Acetate-EDTA Buffer
Tbp TATA-box binding protein
Tris Tris(hydroxymethyl)-aminomethan
U U Uracil
UV Ultraviolett
V v Volume
VEEV Venuzuelan equine encephalitis virus
Vero e6 African green monkey kidney cells
vRNA viral RNA
VSV Vesicular stomatits virus
W w Weight
WB Western Blot
wt Wild type
Z
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